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ABSTRACT 
 
Mouse Embryonic Stem (ES) cells are pluripotent, as they have the ability to differentiate 
into all cell types of the embryo. Many protocols have been established to differentiate ES 
cells into the desired cell type in vitro. However, the identification of molecular machinery 
involved in ES cell biology will increase the knowledge of embryo development and will 
improve the use of ES cell for regenerative medicine. To identify genes involved in 
pluripotency and differentiation we developed a systematic approach based on the 
screening of a shRNA library. The results of the screening shed light on an uncharacterized 
gene, we named Dies1 (Differentiation of Embryonic Stem cells) given its effect on ES 
cell differentiation. Dies1 knock-down affected proper ES cell differentiation into neurons, 
astrocytes and cardiomyocytes. Dies1 knock-down cells, in fact, maintained the expression 
of undifferentiated markers such as Oct3/4, Nanog and Alkaline Phosphatase in conditions 
promoting differentiation. In addition, the growth of Dies1 knock-down cells was 
independent from LIF. Dies1 suppression exerted its effect on ES cell differentiation in 
vivo and in vitro, giving rise to teratoma smaller than controls when Dies1 knock-down 
cells are injected into nude mice. The in silico analysis of Dies1 sequence indicated that it 
possesses a trans-membrane domain and an Ig-like domain in the putative extra-cellular 
domain of the protein, like many membrane receptors. This analysis was confirmed by the 
staining of Dies1 on cell surface of mouse ES cell and blastocyst. The possible role for 
Dies1 as receptor was also supported by the dominant negative function of Dies1 extra-
cellular domain, whose effect resembled Dies1 suppression. Thus, we investigated the 
involvement of Dies1 in the signaling pathways controlling ES cell pluripotency: LIF and 
BMP4. Dies1 knock-down did not affect the expression of undifferentiated markers such 
as Oct3/4, Nanog, Sox2 and Rex1 and of LIF down-stream targets such as Kruppel like 
factors in undifferentiated conditions. On the other hand, Inhibitory of Differentiation (Id) 
genes, which are BMP4 targets, were down-regulated in Dies1 knock-down cells. This 
down-regulation was dependent on a decreased response to BMP4, as shown by luciferase 
assays and occurred in a Smad dependent manner, as the amount of phosphorylated Smad 
1/5/8 complex was decreased in Dies1 knock-down cells. Moreover, the involvement of 
Dies1 in BMP4 signaling was supported by the direct interaction between Dies1 and 
BMP4 in vitro. The down-regulation of BMP4 targets induced also the up-regulation of 
Nodal/Activin targets, such as Cripto and Lefty1/2. Such a regulation between 
Nodal/Activin and BMP4 was observed also in consequence of the suppression by RNA 
interference of the BMP4-type I receptor Alk3. This phenomenon was not surprising 
because Nodal/Activin and BMP4 belong to the TGF-β superfamily and share the common 
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mediator Smad4 which balances the transcriptional activity of Smad 2/3 (dependent on 
Nodal/Activin) and Smad 1/5/8 (dependent on BMPs). Thus, we hypothesized that the up-
regulation of Nodal/Activin signaling was responsible for the effect of Dies1 suppression. 
To address this point, we treated Dies1 knock-down cells with the specific Nodal/Activin 
inhibitor SB-431542. The treatment with SB-431542 restored proper differentiation ability 
in the absence of LIF, leading to the rescue of Dies1 knock-down effect. Taken together 
our results suggest that the balance between BMP4 and Nodal/Activin exerts a crucial role 
in regulating ES cell pluripotency and differentiation.  
In summary, we have identified Dies1 as novel component of BMP4 signaling pathway 
required for proper ES cell differentiation.  
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INTRODUCTION 
 
1. Embryonic Stem cells: Past and future  
 
Research on teratocarcinoma and Embryonal Carcinoma cells (EC) has been carried out 
over the past 50 years. Teratoma (benign) and teratocarcinoma (malignant) are tumours 
that are most commonly found in the gonads but also occasionally in extragonadal sites. 
Their name, which stems from the Greek word ‘teratos’, describes their appearance, as 
these tumours are composed of a mixture of adult tissues. In 1964 Kleinsmith and Pierce 
demonstrated that a single cell derived from a tumour injected intraperitoneally can 
produce all cell types that are encountered in a teratocarcinoma (Kleinsmith and Pierce 
1964). This finding suggested that teratocarcinoma possess a unique type of stem cell, 
which has the capacity to grow indefinitely, ensuring the malignant nature of the tumour 
and at the same time being able to differentiate into multiple adult cell types. The existence 
of such pluripotent stem cells and the observation of specific structures in the tumours 
similar to early embryos indicated the embryonic origin of teratocarcinoma. Given the 
similarities between mouse EC cells and the cells of early embryos it was tempting to 
investigate whether EC cells retain their embryonic nature. Brinster in 1974 demonstrated 
that EC cells could contribute to the development of chimaeras following injection into the 
mouse blastocyst (Brinster 1974). In the early 1980s the attempt to derive cells similar to 
EC cells directly from the embryo resulted in the isolation of mouse embryonic stem (ES) 
(Evans and Kaufman 1981). ES cells are capable of complete differentiation that gives rise 
to all tissues found in an adult animal. This differentiation takes place in vitro, in vivo, in 
tumours derived from injected ES cells and in chimaeras. Moreover, an ES cell is able to 
give rise to germ cells in chimaeras and the germ cells in turn are able to develop into 
normal, fertile adults. Of great concern is that mouse ES cell differentiation follows the 
same hierarchical steps of embryo development, resulting in an excellent model for 
studying embryo development in vitro. Furthermore, the use of ES cells as a vehicle for 
introducing targeted genetic modifications into the germ line makes ES cells a favourite 
tool for gene function analysis (Solter 2006). Thus, the class of pluripotent cells includes 
EC cells, ES cells and primordial germ cells because of the extensive similarity in the 
expression of various markers between these cell types. These considerations, as well as 
the germ cell origin of spontaneous teratocarcinoma, led to attempts to derive ES-like cells 
from primordial germ cells. These attempts resulted in the isolation of embryonic germ 
cells (Matsui, Zsebo et al. 1992). In most aspects embryonic germ cells are identical to ES 
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cells, although their biology has not yet been studied extensively. It was therefore obvious 
to ask whether ES cells can also differentiate into germ cells. In the last few years, some 
reports have suggested that ES cells can differentiate into cells that are very similar to male 
and female germ cells (Toyooka, Tsunekawa et al. 2003). However, so far there is no 
indication that these cells are completely functional gametes that can support normal 
embryonic development. Recently, great promise for regenerative medicine is given by 
reprogramming of somatic cells into induced pluripotent stem cells (iPS). Takashasi and 
Yamanaka have demonstrated that Oct4, Sox2, Klf4 and c-myc (also known as Yamanaka 
factors) are able to “reprogramming” fibroblasts into pluripotent cells capable to colonize 
ICM and give raise to an high rate of chimaerism (Takahashi and Yamanaka 2006). iPS 
can be induced without c-Myc, but with even lower efficiency (Wernig, Meissner et al. 
2008). Hong and collaborators reported a higher rate of “reprogramming” in fibroblasts 
lacking p53 into iPS cells even without the Myc retrovirus. The p53 deletion also promoted 
the induction of integration-free mouse iPS cells with plasmid transfection. Thus, the 
suppression of p53 increases the efficiency of mouse and human iPS cell generation 
(Hong, Takahashi et al. 2009). The links between pluripotency and tumorigenicity are 
exemplified by the fact that genes used to produce iPS cells are oncogenes such as c-myc 
and Klf4 or are linked to tumorigenesis such as Sox2, Nanog, and Oct3/4. Moreover the 
finding that p53 suppression promotes iPS generation demonstrates that the p53-p21 
pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation 
(Kawamura, Suzuki et al. 2009). Of great concern is that nearly all iPS cells described in 
published works have been demonstrated to cause teratoma, proving pluripotency but also 
tumorigenicity, and that mice genetically derived to contain some tissues from iPS cells 
have a malignant tumor incidence of 20%. Thus, these studies reveal that differentiation is 
reversible, and provide strong foundation for the development of technologies that will 
enable the generation of patient-derived pluripotent cells. Immunologically matched 
pluripotent cells are an ideal source for the generation of cells for transplantation, and 
patient-derived pluripotent cells may also be useful tools for the study of disease states and 
drug therapies. 
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2. Pluripotency and differentiation 
 
Mouse embryonic stem (ES) cells are derived from the inner cell mass (ICM) of the pre-
implantation embryo at stage of blastocyst (day 3.5 post coitum). As the embryo develops, 
the ICM gives rise to two distinct cell lineages: the extra-embryonic endoderm, which goes 
on to form the extra-embryonic tissues and the epiblast, which gives rise to the primitive 
ectoderm at the egg-cylinder stage of embryogenesis, from which the embryo proper arises 
(Fig. 1). The primitive ectoderm is the only cell lineage in which pluripotency is 
maintained at this stage of development, enabling it to give raise to all three embryonic 
germ layers and to primordial germ cells. However, as it lacks the ability to differentiate 
into primitive endoderm lineages, the primitive ectoderm is less pluripotent than the cells 
of the ICM. ES cells, in fact, are defined as pluripotent cells because they have the ability 
to give rise to all cells of embryo and adult but they give a limited contribution in extra-
embryonic tissues (Bradley, Evans et al. 1984). In fact, through the ICM that they colonize, 
ES cells can contribute to extra-embryonic mesoderm and therefore to composite annexes 
such as the amnion, the allantois and the yolk sac, but they do not give rise to the 
trophoectoderm, which is consistent with the first cell lineage decision that separates ICM 
and trophectoderm in the blastocyst. However, Niwa and collaborators demonstrated that 
ES cells can differentiate in vitro into trophoectoderm in particular culture conditions such 
as Oct4 suppression by RNA interference (Niwa, Toyooka et al. 2005). Therefore, Niwa 
proposed a new definition of pluripotency for ES cells:  the ability to generate all cell 
types, including the trophectoderm, without the self-organizing ability to generate a whole 
organism (Niwa 2007).  
Mouse ES cell differentiation follows the same hierarchical steps of embryo development. 
Indeed, the same markers are expressed in both ES cell and embryo at same time during 
ES cell differentiation and embryo development. ES cells, in fact, express Oct4 and Nanog, 
which are expressed in ICM, whereas they do not express Cdx2 that marks 
throphoectoderm in the blastocyst. In addition, ES cells give rise to primitive endoderm, as 
ICM does in vivo. Primitive endoderm is recognized by the expression of Gata6 that is 
mutually exclusive with Nanog, which marks pluripotent cells that will give rise to 
primitive ectoderm and then to the three germ layers: ectoderm, endoderm and mesoderm. 
The formation of Embryoid Bodies from ES cells gives rise to the three germ layers. Early 
markers of differentiation of the three germ layers may be recognized in vitro as well as in 
vivo: Sox1 marks ectoderm, Brachyury (also named T) marks mesoderm, Gata4 and Hnf3β 
marks endoderm. Culture conditions influence differentiation process, promoting the 
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formation of a particular germ layer and then the differentiation into a particular cell type. 
To date, lots of protocols for efficient differentiation of ES cells towards the desired cell 
type are available.  
Pluripotency is maintained in ES cell through the prevention of differentiation and the 
promotion of proliferation. Thus, ES cells can self-renew continuously for years if they are 
cultured under conditions preventing their differentiation. Pluripotency can also be re-
established in a differentiated or non-pluripotent cell by exposure of the nucleus to external 
factors. The introduction of the nucleus of a somatic cell into an enucleated oocyte, termed 
Somatic Cell Nuclear Transfer (SCNT) results in a cell that is able to give rise to all cells 
of the mature organism, as demonstrated when this process was used to create Dolly the 
sheep and some others species of mammalian clones subsequently (Wilmut, Schnieke et al. 
2007). More recently, the use of four specific transcription factors, c-myc, Sox2, Oct4 and 
Klf4, has been shown to induce pluripotency in both human and mouse somatic (Takahashi 
and Yamanaka 2006) (Fig. 2). Loss of pluripotency and commitment to specific cell 
lineages results in changes in gene expression that include the down regulation of the key 
pluripotency transcription factors and the up regulation of regulators of differentiation 
(Ivanova, Dimos et al. 2002) (Ramalho-Santos, Yoon et al. 2002) and is accompanied by a 
range of epigenetic alterations including DNA methylation (Carlone, Lee et al. 2005) (Yeo, 
Jeong et al. 2007) and chromatin modifications  (Azuara et al., 2006; Mikkelsen et al., 
2007). Use of ES cells in medicine is a promising scenario for next years. Understanding 
the molecular mechanism underlying ES cell pluripotency and differentiation is crucial to 
develop efficient therapeutic strategies.  
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FIGURE 1: EMBRYO DEVELOPMENT 
 
 
 
From: (Niwa 2007) 
 
Pluripotent cells are stained in green. The inner part of the morula (A) forms the inner cell mass (ICM) of the 
blastocyst (B). The blastocyst is composed by two different cell types: the Inner cell mass (ICM) and the 
trophoectoderm. The ICM contains pluripotent cells which will give rise to all cells of the embryo. Thus, ES 
cells are isolated from ICM. In the late blastocyst (C) the ICM gives rise to primitive endoderm (Gata6 
positive cells) and to the epiblast (Oct4 and Nanog positive cells). The primitive ectoderm origins from the 
epiblast. When gastrulation occurs (D), primitive ectoderm gives rise to three germ layers: ectoderm, 
mesoderm and endoderm.     
 
 
 
FIGURE 2:  THREE WAYS TO OBTAIN PLURIPOTENT CELLS 
 
From: (Johnson, Shindo et al. 2008) 
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3.The transcriptional network regulating ES cell pluripotency  
 
ES cells require extrinsic growth factors, such as LIF, for the maintenance of pluripotency 
in culture. These extrinsic factors are responsible for the maintenance of a network of key 
transcription factors within the cell that controls pluripotency. This network includes the 
homeodomain transcription factor Oct4 (Niwa, Miyazaki et al. 2000), the variant 
homeodomain transcription factor Nanog (Chambers, Colby et al. 2003) and the high 
mobility group (HMG)–box transcription factor Sox2 (Avilion, Nicolis et al. 2003) (Fig. 
3). 
Oct3/4 is a POU domain transcription factor that is expressed by all pluripotent cells 
during mouse embryogenesis, in mouse Embryonic Stem cell lines as well as in Embryonic 
Germ cell lines, even if its expression is weaker in germline stem cells. Oct3/4 deficient 
mouse embryos only develop to a stage that looks like a blastocyst, and although cells are 
allocated to the interior, these blastocysts are composed of trophectodermal cells. As these 
structures lack a genuine ICM, they cannot be used to produce ESC cell lines (Nichols, 
Zevnik et al. 1998). Oct4 has therefore been viewed as being involved in preventing 
trophoectoderm and perhaps somatic cell differentiation from the ICM, as well as being 
crucial for maintaining the pluripotent state during embryonic development. An enhancer 
containing Oct3/4 and Sox2 binding motifs, which is highly active in undifferentiated ES 
cells but not in differentiated cells regulates the expression of most pluripotency associated 
genes, including Fgf4, Utf1, Fbxo15, Lefty1 and Nanog. Oct3/4and Sox2, which bind 
independently to their respective binding motifs act synergistically to activate this 
enhancer (Yuan, Corbi et al. 1995). 
Sox2 is a member of the HMG-domain DNA-binding-protein family that is implicated in 
the regulation of transcription and chromatin architecture. Sox2 is expressed in ES cells, 
but it is also expressed in neural stem cells. The Oct–Sox enhancers are important in 
promoting the expression of Oct3/4 and Sox2 themselves, suggesting that these two 
transcription factors are regulated by a positive-feedback loop (Chew, Loh et al. 2005). 
Chromatin immuno-precipitation studies in both human and mouse ES cells indicate that 
Oct3/4 and Sox2 cooperatively activate or repress a set of genes through their Oct–Sox 
enhancers. However, neither Oct3/4 nor Sox2 are able, even if over-expressed, to sustain 
ES cell self-renewal in the absence of LIF in vitro. 
On the contrary, the homeodomain transcription factor Nanog was found to confer LIF-
independence to ES cells. However, the physiological levels of Nanog in ES cells do not 
prevent their differentiation after LIF withdrawal. On the contrary, mouse ES cells over-
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expressing Nanog are resistant to the spontaneous differentiation that occurs after LIF 
withdrawal (Chambers, Colby et al. 2003). The persistence of Nanog therefore seems to 
delay, rather than block, the differentiation of ES cells. On the other hand, Nanog–/– 
mouse ES cells differentiate slowly into extra-embryonic endoderm lineages, which is 
consistent with the absence of a primitive ectoderm in Nanog–/– embryos at E5.5 in vivo 
(Mitsui, Tokuzawa et al. 2003) (Silva, Nichols et al. 2009). However, although they are 
prone to differentiate, ES cells can self-renew indefinitely in the permanent absence of 
Nanog. Expanded Nanog null cells colonize embryonic germ layers and exhibit 
multilineage differentiation both in fetal and adult chimaeras. Although they are also 
recruited to the germ line, primordial germ cells lacking Nanog fail to mature on reaching 
the genital ridge. Thus, Nanog is dispensable for expression of somatic pluripotency in 
vivo but is specifically required for formation of germ cells (Chambers, Silva et al. 2007). 
Of great concern is that Nanog expression levels are not constant in ES cells. Thus, 
Chambers and collaborators proposed that Nanog regulates the efficiency of self-renewal 
in a manner analogous to a rheostat. In this paradigm, fluctuating Nanog levels in wild-
type cultures confer a variable resistance to differentiation upon individual embryonic stem 
cells. Low levels of Nanog may constitute a ‘window of opportunity’ in which intrinsic or 
environmental perturbations can become consolidated into a lineage commitment decision, 
or may be reversed by re-expression of Nanog. Nanog can block primitive endoderm 
differentiation and neuronal differentiation (Ying, Nichols et al. 2003). Moreover, Nanog 
has been shown to interact with Smad1 to inhibit the expression of Brachyury (Suzuki, 
Raya et al. 2006), blocking mesodermal differentiation and with another transcription 
factor involved in maintenance of pluripotency, Sall4. Nanog and Sall4 form a positive 
regulatory loop for their expression (Wu, Chen et al. 2006). A feedback loop in which 
Oct3/4, Sox2 and Nanog function to maintain their expression promotes continuous ES 
cells self-renewal (Loh, Wu et al. 2006). (Ivanova, Dobrin et al. 2006). This loop 
determines the differentiation fate of ES cells by influencing the expression of transcription 
factors, such as Cdx2 (which promotes trophoectodermal differentiation) and Gata6 (which 
promotes primitive endoderm differentiation). However, during mouse development, 
Nanog transcription is down-regulated in the epiblast and in early primitive ectoderm 
(Hart, Hartley et al. 2004), where Oct3/4 and Sox2 continue to be expressed (Avilion, 
Nicolis et al. 2003) (Rosner, Vigano et al. 1990). Moreover Nanog expression levels in P19 
embryonal carcinoma (EC) cells is much lower than that in ES cells, although both EC and 
ES cells express similar levels of Oct3/4 and Sox2 (Chambers, Colby et al. 2003). This 
suggests that the positive-feedback circuitry in the pluripotent transcription factor network 
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does not always require Nanog, and that the transcription factor network can establish a 
different stable circuit that maintains the levels of Oct3/4 and Sox2 expression with or 
without Nanog. The transition of the pluripotent transcription factor network to either the 
trophoectodermal or extra-embryonic/endodermal network is most likely to be regulated by 
the presence or absence of extracellular signals, such as the removal of LIF from mouse ES 
cells or the formation of EBs. However, the activation of Cdx2 or the repression of Oct3/4 
might occur in mouse ES cells under particular culture conditions. This tallies with 
evidence that Oct3/4 and Cdx2 compete with each other to be expressed during blastocyst 
formation, and with evidence that Oct3/4 expression is dominant in the ICM. Therefore, 
the gatekeeper function of Nanog, which is an Oct3/4 target and prevents extra-embryonic 
endoderm differentiation, appears to be more important in mouse ES cells, as these cells 
are regulated by extra-cellular signals. Indeed, Nanog could be at the hub of these multiple 
signal transduction pathways. Nanog expression, in fact, is regulated by extrinsic factors, 
such as Wnts (Pereira, Yi et al. 2006) and LIF. Klf4 and Klf5, together with Klf2, were 
shown to form a Klf-based molecular circuitry that regulates ES cell self-renewal by 
activating Nanog expression (Jiang, Chan et al. 2008) (Hall, Guo et al. 2009). These 
members of the Kruppel-like transcription factors family, are direct targets of LIF 
(Bourillot, Aksoy et al. 2009), thus linking Nanog and LIF. Klf4 is one of the 4 Yamanaka 
factors, playing a very important role in reprogramming somatic cells into induced 
pluripotent stem cells (iPS) (Takahashi and Yamanaka 2006) and is able to maintain 
pluripotency in combination with Tbx3 in the absence of LIF (Niwa, Ogawa et al. 2009). 
However both Klf2 and Klf5 are able to work in “reprogramming” experiments, suggesting 
a functional redundancy of these three transcription factors (Nakagawa, Koyanagi et al. 
2008).  This is supported by the fact that they share common regulation of many genes and 
that the same DNA binding site has been identified for these 3 transcription factors. Klf5 
play a crucial role in embryo development in vivo, as Klf5 knock-out mice die before 
gastrulation (Shindo, Manabe et al. 2002), showing aberrant blastocyst formation (Ema, 
Mori et al. 2008). 
In our laboratory we have demonstrated a unique role for Klf5 in ES cell self-renewal 
(Parisi, Passaro et al. 2008). Klf5 is strongly expressed in ES cell and in blastocyst (E 3.5), 
whereas it is down-regulated when differentiation occurs, being undetectable 48 hours after 
the induction of ES cell differentiation in vitro and in the epiblast of gastrulating embryos 
at E 6.5. I contributed to the characterization of Klf5 function in ES cells, analyzing the 
effect of Klf5 suppression by RNA interference. Klf5 knock-down causes a strong down-
regulation of Oct4, Sox2 and Nanog expression. Thus, ES cells were Klf5 is suppressed 
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(Klf5 KD cells) show aberrant expression of mesodermal and trophoectodermal markers 
which are undetectable in then controls. Indeed, about 12% of Klf5 KD cells express 
Brachyury (mesodermal marker) and 11% express Cdx2 (trophoectodermal marker). The 
aberrant expression of these differentiation markers is coherent with the down-regulation 
of Oct4, Sox2 and Nanog. This effect is specific of Klf5, as Klf4 KD cells do not show a 
significant down-regulation of Oct4, Sox2 and Nanog in our culture conditions.  
In this work we demonstrate that Klf5 directly controls Oct4 and Nanog with ChIP analysis 
and luciferase assays. The involvement of Klf5 in the transcriptional circuitry which 
controls ES cell self-renewal and proliferation is also supported by the fact that Klf5 over-
expression alone is able to maintain undifferentiated markers such as Alkaline 
Phosphatase, Oct4 and Nanog when cells are grown in the absence of LIF. 
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FIGURE 3: THE TRANSCRIPTIONAL NETWORK REGULATING ES CELL SELF-
RENEWAL AND PLURIPOTENCY 
 
 
 
 
 
 
 
Modified from: (Ivanova, Dobrin et al. 2006) 
 
Many transcription factors such as Oct4, Sox2 and Nanog form a core transcriptional network that regulates 
ES cell pluripotency. This network blocks differentiation and promotes proliferation. Moreover, Oct4, Sox2 
and Nanog are involved in the regulation of their own expression each other, indicating that a positive 
feedback loop sustains the network. 
 
 
 
 
 
 
 
 
 
 
 16
4. Extrinsic factors are necessary for maintaining ES cell pluripotency in vitro 
 
The maintenance of pluripotency within ES cells requires extrinsic factors, either added to 
the growth medium or provided on a feeder layer of differentiated cells (Smith, Heath et al. 
1988) thereby creating an appropriate external signalling environment (Fig. 4). 
 
FIGURE 4: PATHWAYS REGULATING ES CELL SELF-RENEWAL AND 
PLURIPOTENCY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A transcriptional network including Oct4, Sox2 and Nanog, maintains ES cell undifferentiated. This 
transcriptional network is positively regulated by feed-back loop and is sustained by signals present in the 
serum. Leukemia inhibitory factor (LIF) is necessary, even if not sufficient, for sustaining the core 
transcriptional network and thus for maintaining ES cells undifferentiated. The binding of LIF to its receptor 
promotes the phosphorylation and, in turn the activation of the transcription factor STAT3. STAT3 is 
involved in control of proliferation, promoting the transcription of c-myc, and sustains the core 
transcriptional network regulating the transcription of other transcription factors, such as Kruppel-like factors 
(Klfs). Moreover, STAT3 works in combination with Nanog in regulating some genes and in combination to 
BMPs-dependent Smads. BMPs-dependent Smads regulate the transcription of Id genes which block neural 
commitment. Thus, BMP4 is required for maintaining ES cells undifferentiated. BMP4 exerts its effect also 
blocking ERK phosphorylation which is a pro-differentiative signal. Surprisingly, LIF promotes ERK 
phosphorylation, suggesting that LIF regulates a fine balance between self-renewal and differentiation. Wnts 
are also involved in the control of ES cell self-renewal, promoting the transcription of STAT3 and balancing 
signals sustaining self-renewal and promting differentiation. The involvement of Wnts is suggested also by 
the inhibitory effect of GSK3 kinase on this process. PI3 kinase activity, sustained by LIF, blocks GSK3 
kinase, promoting survival and proliferation.  
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4.1. LIF 
The factor required to sustain self-renewal of mouse ES cells is the leukaemia inhibitory 
factor (LIF) (Smith, Heath et al. 1988). LIF is not required for pluripotency of the ICM in 
vivo (Nichols, Chambers et al. 2001) and is unable to maintain pluripotency in human ES 
cells suggesting that alternative mechanisms function in the maintenance of pluripotency 
within these contexts. LIF exerts its effect by binding to the LIF receptor (LIFR)–gp130 
heterodimer receptor on the cell membrane and activating the signal transducer and 
activator of transcription-3 (STAT3). In the presence of LIF in the culture medium, STAT3 
binds to phosphor-tyrosine residues on activated LIFR–gp130 heterodimer receptors 
(Niwa, Burdon et al. 1998) and undergoes phosphorylation and homodimerization. 
Phosphorylated STAT3 dimers then translocate to the nucleus, where they function as 
transcription factors. A conditionally active form of STAT3 that is induced by tamoxifen (a 
STAT3–oestrogen-receptor (ER) fusion protein) (Matsuda, Nakamura et al. 1999) can be 
used to maintain the pluripotent phenotype when LIF is removed from the culture media.  
In addition to the pathway leading to STAT3 nuclear translocation, the intracellular 
domains of the LIFR–gp130 heterodimer can, upon binding to LIF, recruit the non-receptor 
tyrosine kinase Janus (JAK) and the anti-phospho-tyrosine immunoreactive kinase (TIK) 
and activate other pathways. The treatment of ES cells with LIF also induces the 
phosphorylation of extracellular signal-regulated protein kinases, ERK1 and ERK2 and 
increases mitogen-activated protein kinase (MAPK) activity (Matsuda, Nakamura et al. 
1999) which are pro-differentiative signals. This occurs through activation of a bridging 
factor between the cytokine and the MAPKs the widely expressed tyrosine phosphatase Src 
homology Sh domain 2 containing protein tyrosine phosphatase. Functional inactivation of 
SHP-2 facilitates self-renewal (Burdon, Stracey et al. 1999) suggesting that LIF stimulates 
self-renewal by co-activating positive and negative signaling pathways in a coordinated 
manner. The most known STAT3 direct target is the proto-oncogene c- Myc. The forced 
expression of a mutated form of c-Myc temporarily inhibits the differentiation of mouse 
ES cells induced by withdrawal of LIF (Cartwright, McLean et al. 2005). Recently 
Bourillot and collaborators identified 22 STAT3 target genes whose knock-down induces 
spontaneous differentiation (Bourillot, Aksoy et al. 2009). The 22 identified genes encode 
transcription factors, various types of proteins involved in protein and nucleic acid 
modification (serine/threonine kinases, sulfatase, and deadenylase), adhesion molecules, 
extra-cellular matrix and cytoskeleton associated proteins, and a stress-response factor. 
They include Kruppel like factors Klf4 and Klf5 which are known to play a pivotal role in 
the maintenance of the undifferentiated state (Jiang, Chan et al. 2008), as mentioned 
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before, Smad7 which is a regulator of TGF-β superfamily signaling and Sgk. Sgk encodes 
the protein kinase B (PKB)-related protein serum and glucocorticoid-inducible kinase. 
SGK is a downstream effector of the PI3K/3-phosphoinositide-dependent protein kinases 
(PDK) signaling pathway, which contributes to the maintenance of the undifferentiated 
state (Paling, Wheadon et al. 2004). The LIF/STAT3 and LIF/PI3K pathways may act 
synergistically to activate SGK and promote self-renewal. SGK-like PKB inactivates 
glycogen synthase kinase (GSK)-3 in vitro. Inhibition of GSK-3 activity is known to 
facilitate self-renewal of mouse ES cells providing a possible explanatory mechanism for 
SGK action. The observation that both Klf4 and Klf5 are regulated by STAT3 activity 
functionally links the LIF/STAT3 pathway to the regulation of Nanog expression. In 
addition, Bourillot and collaborators observed that Sall4 is also regulated by STAT3. This 
suggests that LIF/STAT3 signaling contributes to the regulation of Nanog transcriptional 
activity, and indirectly feeds the Nanog/Oct4/Sox2 core regulatory network, through 
activation of Klf4, Klf5 and Sall4. Moreover Bourillot and collaborators found that STAT3 
and Nanog co-regulate the expression of 14 genes involved in pluripotency control, 
including Klf4 and Klf5. Of these 14 genes, 12 contain both STAT3 and Nanog binding 
sites identified by ChIP-Seq (Chen, Xu et al. 2008) indicating that they are all direct targets 
of both transcription factors. The identification of pluripotency genes coregulated by 
STAT3 and Nanog helps explain how Nanog overcomes differentiation induced by LIF 
starvation when over-expressed (Fig. 5). 
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FIGURE 5:  STAT3 AND NANOG COOPERATE  
 
 
 
From: (Bourillot, Aksoy et al. 2009) 
 
LIF exerts its function through the activation of STAT3. STAT3 promotes proliferation regulating the 
transcription of c-myc and blocks differentiation repressing some genes involved in. Moreover, in 
combination with Nanog, STAT3 regulates its own transcription and the expression of some other genes such 
as Kruppel-like factors (Klfs). Klfs promote the expression of Nanog functionally linking LIF with the core 
transcriptional network that works within the cells. The common regulation of many genes exerted by Nanog 
and STAT3 may explain why the over-expression of Nanog is able to delay differentiation in the absence of 
LIF.  
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4.2. TGF-β superfamily 
 
LIF is necessary but not sufficient for maintaining ES cell undifferentiated in culture. 
Serum is also required for mouse ES cells. In serum free culture, in fact, LIF is not able to 
block neural differentiation. Bone morphogenetic protein 4 (BMP4) was found to be 
necessary for maintaining ES cell undifferentiated in combination with LIF (Ying, Nichols 
et al. 2003). Bone morphogenetic proteins (BMPs) belong to the Transforming growth 
factor (TGF-β) superfamily that includes also TGF-βs, Activin, Nodal and other related 
proteins. These proteins play an important role in the establishment of body plan and tissue 
differentiation through their effect on cell proliferation, differentiation and migration. The 
model of induction of signalling responses by TGF-β related factors is a linear signalling 
pathway from the type II to the type I receptor kinase to Smad activation, resulting in 
ligand-induced transcription (Derynck and Zhang 2003). In mammals, only 5 type II 
receptors and 7 type I receptors have been identified. Ligand binding to type I receptors 
induces dimerization with type II receptors. The activation of the type I receptor kinase and 
consequent signalling, requires phosphorylation of its GS domain by the type II receptor in 
the heteromeric complex. Phosphorylation of GS-domain enables the recruitment of 
receptor-regulated SMAD proteins (R-SMADs). The type I receptor phosphorylates the R-
SMADs which allows them to form complexes with the common mediator SMAD4. 
SMAD 1,5 and 8 are activated by type I receptors Alk 1,2,3 and 6 whereas SMAD 2,3 are 
activated  by type I receptors Alk 4,5 and 7. In mouse ES cells the most expressed 
receptors are Alk3, which binds to BMP4 and Alk 4 and 7 which bind to Nodal and 
Activin. SMAD complexes accumulate in the nucleus, where they are directly involved in 
regulating the transcription of target genes, both positively and negatively (Schmierer and 
Hill 2007) (Fig. 6). 
TGF-β family signalling has been reported to be involved in the maintenance of ES cell 
identity. Mouse embryos deficient in Smad4 display defective epiblast proliferation and 
delayed outgrowth of the inner cell mass (Sirard, de la Pompa et al. 1998). 
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FIGURE 6: TGF-β SUPERFAMILY SIGNALING 
 
 
 
 
From: (Schmierer and Hill 2007) 
 
Ligand binding to the type I receptors induces dimerization of type I receptors and type II receptors. Type II 
receptors phosphorylate type I receptors that, in turn, recruit SMADs and activate them through 
phosphorylation. TGF-β1, Activin and Nodal exert their function through type I receptors Alk 4,5 and 7 that 
induce SMAD 2-3 phosphorylation, whereas BMPs bind to Alk 1,2,3 and 6 that induce SMAD 1-5-8 
phosphorylation. SMAD 2-3 and SMAD 1-5-8 share the common mediator SMAD4 which is necessary for 
their nuclear translocation and recruitment of cofactors to activate or repress transcription. 
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4.2.1 BMP4  
 
The only BMP dependent type I receptor expressed in the inner cell mass and in ES cells in 
Alk3 (Mishina, Suzuki et al. 1995). Mice lacking Alk-3 (also named BMP type IA 
receptor) exhibit reduced cell proliferation in the epiblast (Mishina, Hanks et al. 2002), 
indicating that BMP signaling plays important roles in the maintenance of mouse ES cell 
identity. Since BMPs are potent inhibitors of neural differentiation in vertebrate embryos 
(Wilson and Hemmati-Brivanlou 1995) the growth stimulatory activities of BMPs should 
be mainly mediated by their inhibitory effects on neural differentiation of mouse ES cells. 
Ying and collaborators (Ying, Nichols et al. 2003) reported that BMP-4 sustains self 
renewal of mouse ES cells in concert with LIF, and that the critical contribution of BMP-4 
to self renewal is mediated by the induction of the helix-loop-helix protein Id (inhibitor of 
differentiation). Id genes encode repressive basic helix-loop-helix (bHLH) factors and have 
been shown to be induced by BMP/Smad in neuroepithelial cells (Nakashima, Takizawa et 
al. 2001) and in C2C12 myoblasts (Lopez-Rovira, Chalaux et al. 2002). The induction of 
Id proteins by BMP has also been reported in differentiating ES cell cultures (Hollnagel, 
Oehlmann et al. 1999) and is dependent by BMP but not by LIF. Moreover, neither activin 
nor TGF-β induces the expression of Id genes indicating that this response is specific to 
SMADs downstream of the BMP receptor. The neurogenic bHLH transcription factors are 
known to be antagonized by direct binding of Id proteins in the developing CNS (Lyden, 
Young et al. 1999). Thus, Id expression may be necessary to prevent continuous neural 
differentiation of ES cells triggered by precocious expression of pro-neural bHLH factors. 
BMP4 regulation of Ids is only part of the story. Qi and co-workers (Qi, Li et al. 2004) 
reported that BMP-4 is necessary for the maintenance of ES cell self-renewal, and that 
effect of BMP-4 is accomplished by inhibition of both extra-cellular receptor kinase (ERK) 
and p38 mitogen-activated protein kinase (MAPK) pathways. Inhibition of the p38 MAPK 
pathway was shown to overcome the block in deriving ES cells from blastocysts lacking 
Alk3. In addition, Lee and collaborators demonstrated that BMP4 is involved in ES cell 
proliferation (Lee, Lim et al. 2009). BMP4, in fact, increases thymidine incorporation and 
induces cyclin D1 expression in a SMAD-dependent manner. Wnt1 seems to be mediate 
BMP4 involvement in control of proliferation because its knock-down blocks BMP4 effect 
on thymidine incorporation and cyclin D1 induction.  
A mechanism of cooperative transcriptional regulation between Smad1 and STAT3 has 
been characterized in neuroepithelial cells. This involves formation of a ternary complex 
particular bridged by the ubiquitous transcriptional coactivator p300 and results in 
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synergistic activation of glial-specific promoters. Ying and collaborators investigated 
whether a complex containing STAT3 and Smads may be formed in ES cells stimulated 
with LIF plus BMP. Immunoprecipation following transfection with 3XFLAG-tagged 
Smad1 indicated that activated STAT3 and Smad1 may colocalize. This conclusion was 
corroborated by co-immunoprecipitation of endogenous phosphorylated Smad1 and 
STAT3 following LIF plus BMP stimulation. These data support the hypothesis that 
BMP4/Smad1 sustains LIF/STAT3 function in mouse ES cells. In parallel, the capacity of 
BMP4 to induce mesodermal and endodermal differentiation is constrained by STAT3, 
probably involving direct as well as indirect mechanisms. Withdrawal of LIF therefore, 
results in a switch in BMP action from supporting self-renewal to promote lineage 
commitment. Taken together this results indicate a tight cross-talk between BMP4 and LIF. 
 
 
 
FIGURE 7: LIF AND BMP4 COOPERATE TO MAINTAIN ES CELL 
UNDIFFERENTIATED 
 
 
 
 
 
 
From: (Ying, Nichols et al. 2003) 
 
LIF redirects the pro-differentiative action of BMP4 to the sustain of pluripotency. In presence of LIF, BMP4 
induces the expression of Id genes blocking neuroectodermal commitment and blocks pro-differentiative 
signals such as ERK phosphorylation. Otherwise, in the absence of LIF, BMP4 promotes differentiation. In 
presence of serum, in fact, BMP4 promotes differentiation into mesoderm and endoderm. On the other hand, 
in serum-free conditions, BMP4 promotes non-neural ectodermal fate, giving rise to epithelioid cells 
committed toward epidermal fate. 
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4.2.2 Nodal/Activin 
 
Nodal involvement in maintenance of ES cell properties is demonstrated by the finding 
that Nodal-deficient mouse embryos exhibit a thick epiblast with very low levels of Oct3/4 
expression (Mesnard, Guzman-Ayala et al. 2006). Nodal itself and its co-receptor Cripto as 
well as Nodal antagonists Lefty1/2 and Bambi (Bmp and Activin membrane bound 
inhibitor) are controlled by the Nodal/Activin pathway through the activation of SMAD 
2/3 complex in mouse ES cells, indicating that auto-regulatory loops regulate the signaling 
(Guzman-Ayala, Lee et al. 2009). The treatment with Nodal/Activin inhibitor SB-431542  
(Inman, Nicolas et al. 2002) dramatically decreases the proliferation of mouse ES cells, 
suggesting that Activin/Nodal signaling is indispensable for proliferation of mouse ES 
cells (Ogawa, Saito et al. 2007). Recently, Activin and Nodal were shown to be sufficient 
to maintain undifferentiated ES cell where E-cadherin is suppressed even in the absence of 
LIF suggesting a role also in maintenance of pluripotency (Soncin, Mohamet et al. 2009). 
Moreover, Activin/Nodal are necessary to maintain the pluripotent status of human ES 
cells (James, Levine et al. 2005). Inhibition of Activin/Nodal signalling by follistatin and 
by over-expression of Lefty or by the Activin receptor inhibitor SB-431542, accelerates 
human ES cells differentiation. Nevertheless, neither Nodal nor Activin is sufficient to 
sustain long-term human ES cells growth in a chemically defined medium without serum. 
Long-term maintenance of pluripotency can be achieved with a combination of Activin or 
Nodal plus FGF2 in the absence of serum. However, this effect of FGF on human ES cells 
pluripotency depends on Activin/Nodal signalling, because it is blocked by SB-431542 
(Vallier, Alexander et al. 2005). Activin/Nodal exert their effect directly controlling the 
expression of Nanog in human embryonic stem cells (hESCs) and in mouse epiblast stem 
cells (EpiSCs) (Vallier, Mendjan et al. 2009). Nanog in turn prevents neuroectodermal 
differentiation induced by FGF signalling and limits the transcriptional activity of the 
Smad2/3 cascade, blocking progression along the endoderm lineage. 
 
4.2.3 Regulation of TGF-β superfamily signalling 
 
TGF-β superfamily signaling is finely regulated. Many regulatory proteins exerts their 
function at different levels.  
a) Many accessory proteins enhance ligand-binding specificity to receptors. For example, 
efficient binding of Nodal to its type I receptor Alk4 and consequent signalling require 
association of fucosylated Cripto with Alk4 (Bianco, Adkins et al. 2002) (Strizzi, Bianco et 
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al. 2005). In parallel, betaglycan and endoglin provide high affinity TGF-β presentation to 
the TGF-β receptor complex.  
b) R-Smads (Smad 1-5-8 and Smad 2-3) and Smad4 contain a conserved MH1 domain and 
C-terminal MH2 domain, flanking a divergent middle linker sequence. Inhibitory Smads 
(Smad 6-7) lack a recognizable MH1 domain, but have a MH2 domain. Both MH1 and 
MH2 domains can interact with selected sequence-specific transcription factors, whereas 
the C-terminus of the R-Smads interacts with and recruits the related coactivators CREB-
binding protein (CBP) or p300. With the exception of Smad2, the MH1 domains of Smads 
can bind to DNA, whereas the MH2 domains mediate Smad oligomerization and Smad 
receptor interaction. Although differentially controlled during development, R-Smads and 
Smad4 are expressed in most, if not all, cell types. In contrast to R-Smad expression, 
expression of inhibitory Smad6 and Smad7 is highly regulated by extra-cellular signals. 
Furthermore, induction of Smad6 and Smad7 by BMP and TGF-β represents an auto-
inhibitory feedback mechanism for ligand induced signalling (Massague 2000). Smad6 and 
Smad7 regulate activation of R-Smads, binding with their MH2 domains to type I receptor, 
preventing recruitment and phosphorylation of effector Smads. Ubiquitin-proteasome 
mediated degradation also controls the levels of Smads post-translationally. The HECT 
(homologous to the E6-AP carboxy terminus) E3 ubiquitin ligases, Smurf1 (Smad-
ubiquitination-regulatory factor 1) and Smurf2 antagonize TGF-β family signalling by 
interacting with R-Smads and targeting them for degradation. Smurf1 interacts with Smad1 
and 5, thereby affecting BMP responses, whereas Smurf2 interacts more broadly with 
different R-Smads, allowing interference with BMP and TGF-β/Nodal/Activin signalling 
(Zhu, Kavsak et al. 1999) (Zhang, Chang et al. 2001). In addition, recruitment of a 
complex of Smad7 with Smurf1 or Smurf2 to type I receptors, results in degradation of 
receptors.  Proteasomal degradation also regulates R-Smad levels after translocation into 
the nucleus. Thus, C-terminally phosphorylated Smad2 can undergo ubiquitination, and 
inhibition of proteasomal degradation enhances its nuclear accumulation (Lo and 
Massague 1999). In contrast to R-Smads, Smad4 is not subjected to ubiquitin mediated 
degradation. However, some tumor-associated mutations allow ubiquitination and/or 
decrease Smad4 stability (Wan, Cao et al. 2002). 
c) TGF-β ligands induce receptor internalization in endosomes, which may be required for 
efficient TGF-β signalling through Smads. Thus, receptor associated proteins may have a 
role in vescicular trafficking as well as facilitating internalization and Smads recruitment to 
receptors.  For example, SARA and Dab2, which are enriched in endosomes and clathrin 
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coated vescicles, bind to both receptors and Smads, promoting Smad phosphorylation 
(Tsukazaki, Chiang et al. 1998). 
d) Some kinases further regulate Smad signalling. The linker region between MH1 and 
MH2 domains contains several serine and threonine residues that can be phosphorylated by 
kinases. Mitogen-activated protein kinases (MAPKs), which are activated by growth 
factors and cytokines, modulate Smad signaling (Funaba, Zimmerman et al. 2002) 
(Kretzschmar, Doody et al. 1999). In the BMP signaling pathway, Erk phosphorylates the 
linker region of Smad1 to inhibit Smad1 nuclear accumulation and transcriptional activity. 
In the TGF-β signaling pathway, activated MAPKs inhibit TGF-β signaling by inducing 
the cytoplasmic retention of Smad2 and/or Smad3 via phosphorylation of the linker region 
Conversely, Kamaraju and Roberts reported that phosphorylation of the Smad3 linker 
region by p38 MAPK was required for maximal transcriptional activation and growth 
inhibition by TGF-β (Kamaraju and Roberts 2005). 
 
4.3. Wnts 
 
Wnt signalling acts synergistically with LIF, regulating STAT3 transcription (Hao, Li et al. 
2006) and with BMP4, mediating cyclin D1 induction (Lee, Lim et al. 2009). Wnt pathway 
activation by 6-bromoindirubin-3'-oxime, a specific pharmacological inhibitor of GSK-3, 
maintains the undifferentiated phenotype in human and mouse ES cells and sustains 
expression of the pluripotent state-specific transcription factors Oct3/4, Rex1 and Nanog 
(Sato, Meijer et al. 2004). Stimulation of the canonical Wnt signaling pathway causes the 
transcriptional coactivator β-catenin to translocate to the nucleus, where it interacts with 
Tcf/Lef proteins to activate target gene. The most important effector of Wnts is T-cell 
factor 3 (Tcf3) which represses Nanog expression, thus demonstrating that a fine 
regulation of the stemness master genes occurs in ES cell (Pereira, Yi et al. 2006). Tcf3 co-
occupies promoters of many genes involved in self-renewal in association with Oct4 and 
Nanog. Thus, Tcf3 also is an integral component of the core regulatory circuitry of ES 
cells. Both Tcf3 depletion and Wnt pathway activation cause increased expression of Oct4, 
Nanog, and other pluripotency factors and produce ES cells that are refractory to 
differentiation (Cole, Johnstone et al. 2008). However, Wnts acts balancing signals 
sustaining pluripotency or promoting differentiation, as shown in vivo. Wnt3-deficient 
embryos, in fact, express high levels of Oct4 (Liu, Wakamiya et al. 1999). The entire 
Wnt3-deficient embryo remains bilayered at gastrulation and continues to express Oct4, 
thus providing Wnt3 requirement in primary axis formation in mice. 
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5. Are extrinsic factor dispensable for maintaining ES cell pluripotency? 
 
Ying and co-workers proposed that the LIF and serum/BMP signals mainly exert their 
action blocking ES cell differentiation. In this view, LIF and BMP4 should act downstream 
of phospho-ERK to block commitment (Ying, Wray et al. 2008). To test this hypothesis 
they used selective small-molecule inhibitors SU5402 and PD184352 to inhibit FGF 
receptor tyrosine kinases and the ERK cascade, respectively. They found that, in 
combination with LIF, either inhibitor replaces the requirement for serum/BMP and 
supports robust long-term ES cell propagation. Lineage commitment does not occur 
despite a reduced expression of Ids proteins due to the absence of BMP4 in growth 
medium. This result, observed with several independent ES cell lines, suggests that the 
minimal requirements for ES-cell self-renewal may be to deflect commitment signals 
emanating from FGF receptor and ERK signalling. However, apoptosis is relatively high in 
cells treated with these two inhibitors (2i) and cells survive poorly at clonal density. To 
overcome these problems they added to the culture medium a glycogen synthase kinase-3 
inhibitor, CHIR99021. ES cell propagation, in fact, was previously reported to be enhanced 
by GSK3 inhibitors. Alone, CHIR99021 enhances survival at low cell density but also 
induces non-neural differentiation. However the combination of all three inhibitors (3i) 
results in a highly efficient expansion of undifferentiated colonies, even at a low cell 
density. These results were confirmed in STAT3 null background confirming that 3i 
dependent ES cell propagation does not involve STAT3 signaling cascade. As consequence 
of results obtained in vitro, Ying and collaborators observed that the derivation of ES cells 
from embryos cultured with the 2 previous described inhibitors SU5402  and PD184352 
(2i) from the 8-cell stage was very efficient. Nichols and collaborators (Nichols, Silva et al. 
2009) used this system to address the ability of the individual epiblast cells to form ES 
cells. They used immunosurgery to isolate inner cell mass (ICM) from 129 embryos 
cultured for 3 days in 2i from the 8-cell stage. They dissociated the ICM and deposited 
single cells into individual wells of 96-well plates in 2i or 2i plus LIF. Of individual cells 
plated in 2i alone, 2 out of 33 (6%) gave rise to undifferentiated ES cell colonies. By 
contrast, 25 out of 46 cells (54%) plated in 2i plus LIF yielded ES cell colonies. Addition 
of LIF to 3i has previously been shown to enhance clonogenicity of ES cells by activation 
of the Stat3 pathway. The colonies produced in 2i alone were morphologically identical to 
those derived in 2i plus LIF. These findings indicate that self-renewal is shared between 
pre-implantation epiblast and ES cells. The intrinsic properties exhibited by mouse ES 
cells seems thus not to be an adaptation to culture, but directly represents autonomous 
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expansion of early epiblast. In the unperturbed embryo, self-renewal is short-lived due to 
the inductive action of Fgf4 and other extrinsic Erk stimuli, but this stimulus can be 
arrested in diapause, during which the epiblast can remain in a naïve state for weeks. ES 
cell lines can most readily be derived from diapause blastocysts (Ying, Wray et al. 2008). 
Upon explant culture, the epiblast will rapidly lose pluripotency and differentiate under the 
influence of Erk signalling (Buehr and Smith 2003). Disrupting this signal with 3i/2i 
prevents this progression and releases ES cells. 
 
 
6. Aim of the project 
 
In our laboratory we performed the screening of a shRNA library to identify genes 
involved in ES cell self-renewal and pluripotency. The knowledge of the molecular 
machinery involved in ES cell biology will improve their use in regenerative medicine and 
the knowledge of embryo development. By using the screening approach we found 50 
genes. First of all, we focused on the transcription factor Klf5 (Kruppel-like factor 5) and 
on its specific function in ES cell (Parisi, Passaro et al. 2008). More in detail, I analysed 
the effect of Klf5 suppression in ES cell and the role of this transcription factor within the 
network that controls ES cell self-renewal. In the last two years, I focused on the unknown 
gene riken cDNA 4632428N05, we named Dies1 which stands for Differentiation of ES 
cell 1. The investigation of Dies1 function is the object of this thesis. Dies1 was 
characterized as a new player required for proper ES cell differentiation. Indeed, Dies1 was 
identified as novel component of BMP4 signaling pathway, shedding light on the crucial 
role of the balance of TGF-β superfamily signaling in the control of ES cell pluripotency. 
A part of the work described here was published on “The Journal of Biological Chemistry” 
in December 2009 (Aloia, Parisi et al. 2009).  
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MATERIAL AND METHODS 
 
Cell culture 
E14Tg2a (BayGenomics) mouse ES cells were maintained on feeder-free, gelatine coated 
plates in the following medium (ES cell medium): GMEM (Sigma) supplemented with 
2mM glutamine (Invitrogen), 100U/ml penicillin/streptomycin (Invitrogen), 1mM sodium 
pyruvate (Invitrogen), 1x non essential amino acids (Invitrogen), 0.1 mM β-
mercaptoethanol (Sigma), 10% FBS (Hyclone), 2 mM glutamine (Invitrogen), and 103 
U/ml leukemia inhibitory factor (LIF) (Chemicon).   
For neural differentiation cells were seeded at the density of 3x103 cells for cm2 . Cells 
were cultured in neural differentiation medium (NDM): Knockout Dulbecco’s minimal 
essential medium supplemented with 10% Knockout Serum Replacement (both from 
Invitrogen),0.1mM β-mercaptoethanol, 2 mM glutamine, 100 U/mL penicillin-
streptomycin. 
To perform the screening, the promoter of β-actin gene was inserted in pEGFP N1 vector 
(pCBA-GFP vector). A clone stably transfected with pCBA-GFP was selected for futher 
experiments  and renamed α1 tubulin-GFP ES cell line.  
α1-tubulin-EGFP cell line was plated in gelatine-coated 96-wells and transfected after 12h 
with shRNAs using ArrestIn (both from Open Biosystems). Recombinant clones were 
selected with puromycin (2µg/ml, Sigma) for three days. The selected clones were 
trypsinised into a single cells suspension and plated in ES cell medium (see above) at low 
confluence (1-5x103 cells/cm2) for four-five hours to allow them to attach to the plate. 
Then, ES cell medium were replaced with NDM (see above) that was changed on 
alternated days. Within 4-5 days of differentiation, EGFP-positive cells appear. Starting 
from day 7 of differentiation onward, a population of cells showing a strong EGFP 
expression (neurons) was observed which produce a complex network surrounding the 
clones. We analyzed the presence/absence of EGFP by observation at fluorescence 
inverted microscope (Leica Microsystems) at different time points (4, 7, 10 days of 
differentiation).  
HEK 293 were cultured in DMEM (GIBCO) supplemented with 10%FBS (HighClone), 2 
mM glutamine and100 U/mL penicillin/streptomycin.  
ES cells were transfected with Lipofectamine 2000, following manufacturer’s instructions.  
HEK 293 cells were transfected using calcium phosphate transfection method.  
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 RNA interference 
Open Biosystems Mouse pSM2 retroviral shRNA mir was used as source of shRNAs. 
Sequences of shRNAs used are listed below: 
 
D
 
ies1 shRNA1:  
T
G
 
GCTGTTGACAGTGAGCGAGGAACCCTGCTCCTTGCTATTTAGTGAAGCCACA
ATGTAAATAGCAAGGAGCAGGGTTCCCTGCCTACTGCCTCGGA 
Oct3/4 shRNA: 
TGCTGTTGACAGTGAGCGCGCAGAAGGAGCTAGAACAGTTTAGTGAAGCCACA
GATGTAAACTGTTCTAGCTCCTTCTGCATGCCTACTGCCTCGGA 
 
Id1 shRNA: 
TGCTGTTGACAGTGAGCGCGCAGCATGTAATCGACTACATTAGTGAAGCCACA
GATGTAATGTAGTCGATTACATGCTGCATGCCTACTGCCTCGGA 
 
Id3 shRNA:  
TGCTGTTGACAGTGAGCGACCTGATTATGAACTCTATAATTAGTGAAGCCACA
GATGTAATTATAGAGTTCATAATCAGGGTGCCTACTGCCTCGGA 
 
Dies1 shRNA2 (targeting Dies1 3’UTR) was generated using Open Biosystems protocols 
available on line. The sequence is: 
 
TGCTGTTGACAGTGAGCGCGGAACCACTGTGAGCTCATTATAGTGAAGCCACA
GATGTATAATGAGCTCACAGTGGTTCCTTGCCTACTGCCTCGGA 
 
Non silencing siRNA, Dies1 siRNA (riken 4632428N05), Nanog siRNA, Sox2 siRNA and 
Alk3 siRNA are available in Dharmacon Smart Pool library. 
 
 
Plasmids 
The vector used for all the constructs is pCBA-GFP. This vector was derived from p-
EGFPN1, with β-actin promoter instead of CMV. Dies1 cDNA was obtained from NIH 
Mammalian Gene Collection, Invitrogen clone IMAGE: 3488482. Dies1 cDNA was 
inserted using BamH1-NotI restriction sites, using the following oligonucleotides: 
5’BamH1 Dies1 full-length for: 
GGATCCGCCGCCATGGGTGTCCCCGCGGTCCCAGAGGCCAGC  
3’NotI/HindIII Dies1 full-length rev: 
GCGGCCGCAAGCTTTTAGATGGCTTCAGAGTTAGGGGAGTCAG 
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Then, using the inserted site HindIII and Not I, 3xFLAG was added at 3’end of Dies1 
sequence with in vitro annealing: 
HindIII 3xflag: 
AGCTTGACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGATTAC
AAGGATGACGATGACAAGTAAGC  
NotI rev 3xflag: 
GGCCGCTTACTTGTCATCGTCATCCTTGTAATCGATATCATGATCTTTATAATC
ACCGTCATGGTCTTTGTAGTCA 
Thus, Dies1 full-length 3xFLAG was generated.  
By this vector, all the others constructs were generated.  
Dies1-ECD 3xFLAG was obtained by replacing Dies1 full-length, with Dies1 extra-
cellular domain (ECD) (aa 1-189), with the following oligonucleotides: 
5’BamH1 Dies1-ECD for: 
GGATCCGCCGCCATGGGTGTCCCCGCGGTCCCAGAGGCCAGC  
3’Hind III Dies1-ECD rev: 
AAGCTTTTACGTGATGCTGTCACTGTCCTGCTCATTAGACG 
Both Dies1 full-length and Dies1-ECD were tagged with HA and with Strep-tag replacing 
3xFLAG (HindIII/NotI) with the following oligonucleotides: 
HindIII streptag for 
CTTCTCAAATTGTGGGTGGCTCCAGCCGCCGCC TAAGC 
NotI streptag rev 
TTAGGCGGCGGCTGGAGCCACCCACAATTTGAGAAGA 
Thus Dies1 full-length/ECD- Streptag was generated. 
HindIII HA for 
TACCCATACGATGTTCCAGATTACGCTTAAGC 
NotI HA rev 
TTAAGCGTAATCTGGAACATCGTATGGGTAA 
Thus Dies1 full-length/ECD- HA was generated 
 
RNA isolation, reverse transcription and real-time PCR analysis 
Total RNAs were extracted using Trizol ultra pure reagent (Invitrogen) according to the 
manufacturer’s instructions and subsequently incubated with DNAse RNAse-free 
(Ambion) to minimize genomic DNA contamination. was used for reverse transcription. 
Total RNA (2 μg RNA/reaction) was reverse transcribed with SuperScript Vilo 
transcriptase (Invitrogen) using random hexamers (Amersham). Real Time RT-PCR was 
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carried out on ABI PRISM 7900HT Sequence Detection System (Applied Biosystems) 
using Power SYBR Green PCR Master mix (Applied Biosystems).  Gene specific primers 
used for amplification are listed in the table below: 
 
Gene Forward primer  Reverse primer  
Gapdh GTATGACTCCACTCACGGCAAA TTCCCATTCTCGGCCTTG 
Dies1 AGGCAGGCAAAGGCTCG CTGTCCTGCTCATTAGACGCC 
Oct3/4 AACCTTCAGGAGATATGCAAATCG TTCTCAATGCTAGTTCGCTTTCTCT 
Nanog TCAGAAGGGCTCAGCACCA GCGTTCACCAGATAGCCCTG 
Sox2 CTGCAGTACAACTCCATGACCAG GGACTTGACCACAGAGCCCAT 
Stat3 TTCCCATTCTCGGCCTTG TCTTGATGACTAAGGGCCGGT 
Klf2 CCAACTGCGGCAAGACCTAC CAATGATAAGGCTTCTCACCTGTGT 
Klf4 ACTCACACAGGCGAGAAACCTTAC TCAGTTCATCGGAGCGGG 
Klf5 GGTCCAGACAAGATGTGAAATGG TTTATGCTCTGAAATTATCGGAACTG 
Id1 GAGCAGCAGGTGAACGTCCT TCCTTGAGGCGTGAGTAGCA 
Id2 TTCCCATTCTCGGCCTTG TGATGCAGGCTGACGATAGTG 
Id3 GTAAGAGCCCGTCGACCGA GCAGTGGTTCATGTCGTCCA 
Nodal CCTCCAGGCGCAAGATGT ACCAGATCCTCTTCTTGGCTCA 
Lefty1 CTCGGGTCACCATTGAATGG TGGACACGAGCCTAGAATCGA 
Lefty2 GTCACCATTGAATGGCTGAGAG GTGGATGGACACGAGCCTAGAG 
Rex1 TCATCTTCTTGCTCTTCTTCAGAGTC TAGTCCATTTCTCTAATGCCCACAG 
Cripto ATCCAGTGTGGTTTTGCTTGTG TCTCTGATGGCAAGGTCTCTCC 
Alk3 CTCATGTTCAAGGGCAGAATCTAG TTTCTGGCTTCTTCTGGTCCAA 
 
 
Generation of Dies1 antibody 
Dies1 was an uncharacterized and unpublished gene. To further explore Dies1 expression 
we generated polyclonal antibodies using the N-terminal part of the protein as it was 
predicted to be strongly immunogenic in rabbit. Firstly, we purified Dies1 extra-cellular 
domain (aa 39-168) fused to GST domain from bacteria (Escherichia Coli BL21). This 
protein was injected into 2 rabbits by PRIMM and then the serum (named serum 1 and 2) 
was collected after one month. We tested both serum by Western Blot but they didn’t get 
satisfying results. Thus, we decided to generate others antibodies using a peptide as 
immunogen. The peptide ELKNHHPEQRFYGSME (aa 149-164) was synthesized by 
PickCell Laboratories, injected into 2 rabbits and after one month serum (named 11375 and 
11376) was collected. We tested both serum and selected the serum 11375 as it gave better 
results in western-blot and immuno-staining analysis.  
 
Protein extraction and western blotting 
To obtain protein extracts, cells were lysated in RIPA buffer: 20 mM Tris-HCl (pH 7.5) 
150 mM NaCl, 1 mM EDTA, 1% Triton, 1% sodium deoxycholate, 2,5 mM sodium 
pyrophosphate,1 mM b-glycerophosphate, 1 mM Na3VO4. The lysates were separated by 
SDS-PAGE (Biorad Laboratories) and transferred to PVDF membrane (Millipore). The 
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membrane was probed with the following antibodies: Anti-Oct3/4 (Santa Cruz), anti-
GAPDH (Santa Cruz), anti FLAG M2 (Sigma), anti HA (Upstate), anti pTyr (Santa Cruz), 
anti Nanog (Calbiochem), anti Smad1 (Epitomics), anti p-Smad 1/5/8 (Cell signaling), anti 
Smad2 (Cell Signaling), anti p-Smad 2/3 (Cell Signaling). Antibody-protein complexes 
were detected by HRP-conjugated antibodies (Santa Cruz and Amersham Biosciences) and 
ECL (Amersham Biosciences). 
 
Immunoflurescence of cells and embryos 
ES cells, HEK 293 and blastocysts were fixed in 4% paraformaldehyde and permeabilized 
with 0.2% TX-100 in 10% normal goat serum (Dako Cytomation, Glostrup, Denmark, 
http://dakocytomation.com)/1% BSA in 1X PBS for 15 min at room temperature. Thus the 
samples were incubated with primary antibodies at the following working dilutions: anti- 
βIII-tubulin (1:400; Sigma-Aldrich), anti-Oct3/4 (1:100; Santa Cruz), anti-Nanog (1:100, 
Calbiochem), anti-Flag (1:250; Sigma), anti-E cadherin (1:100 Sigma), anti Dies1 (1:250 
serum 11375). Following primary antibodies incubation, either cells or blastocyst were 
incubated with appropriate secondary antibodies detecting mouse, rabbit, goat and rat IgG 
conjugated with Alexa Fluor 594 or 488 (Molecular Probes). Images were captured with an 
inverted microscope (DMI4000, Leica Microsystems) or with a confocal microscope (LSM 
510 META, Zeiss). 
 
Alkaline Phosphatase assay 
ES cells were seeded at low density (1x103 for 10 cm plates) and then cultured for 6 days 
in medium (see above) not supplemented by LIF. Then they were fixed with formaldehyde 
and stained with Red Violet (Sigma). 
 
FACS analysis 
5x106 cells were resuspended in 1 ml of SALINA GM+EDTA. Then the cells were fixed 
adding ethanol at kept overnight at 4°C. The pellet obtained after centrifugation at 1000 
rpm was resuspended in 2 ml of iodure propidium (20 μg/ml) and then analysed with a 
FACScanto (BD Bioscence).  
 
Teratoma Formation 
Nude mice were injected subcutaneously with 2x106 ESC cells transfected with Dies-1 
shRNA (left side) or NS shRNA (right side). Four weeks after the injection, tumors were 
surgically dissected from the mice. Samples were fixed for 24 hours in 4% 
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paraformaldehyde, and embedded in paraffin. Sections were stained with heamatoxylin and 
eosin. 
 
Luciferase reporter assays 
Firefly and Renilla luciferase activities were measured with the dual-luciferase reporter 
system (Promega) by Sirius Luminometer (Berthold Detection Sistems). Cells were 
transfected with Id BRE luc or with CAGA luc (kindly provided by Caterina Missero) and 
with NS siRNA and Dies1 siRNA. 16 hours post-transfection BMP4 30 ng/ml (R&D), 
Activin (50 ng/ml), Nodal (4 μg/ml) were added to the following medium: GMEM 
supplemented with KSR and LIF (see above). After 24 hours lysates were harvested. The 
data generated were expressed as relative to mock transfected cells or to non-silencing 
siRNA control transfection, after normalization to Renilla luciferase reading. All 
transfection experiments were repeated in triplicate.  
 
Elisa assay 
ELISA was performed by using Delfia EU labeling kit (Perkin Elmer) following the 
manufacturer instruction. Briefly, 96 well plates Strep-MAB Immunocoated (IBA) were 
incubated at 4°C for multiple rounds with the conditioned medium of HEK293 cells 
secreting Strep-tagged Dies1 extracellular domain (ECD). Then, 100 ng/ml of BMP4 
(R&D), marked with Europium (Perkin Elmer), was added to the wells and incubated for 
2h at RT. For competition assay some wells were pre-treated with unlabelled BMP4 at 
reported concentration. Fluorescence signal was detected with Envision 2102 Multilabel 
Reader (Perkin Elmer). 
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RESULTS 
 
Identification of genes involved in mouse ES cell differentiation 
 
We developed a systematic approach based on the screening of a shRNA library (Open 
Biosystems) covering all known mouse transcriptome (Silva, Li et al. 2005). Our goal was 
to identify genes involved in ES cell self-renewal and/or differentiation. To this aim, we 
generated an ES cell line expressing the gene reporter Enhanced Green Fluorescent Protein 
(EGFP) under the control of the promoter of α1 tubulin gene, which is a specific marker of 
neuronal precursors and young neurons (Schmandt, Meents et al. 2005). α1 tubulin-GFP 
cell line showed proper differentiation ability and retained all the properties specific of 
wild-type E14 Tg2A ES cells. To obtain neural differentiation, α1 tubulin-GFP cells were 
cultured in monolayer with neural differentiation medium (NDM), which contains knock-
out medium supplemented with knock-out serum, a serum-free defined cocktail of factors. 
In these culture conditions, α1 tubulin and, in turn, EGFP started to be expressed at day 4 
of differentiation and strongly increased day by day during differentiation until day 13. In 
fact, 10-13 days were necessary to gain complete differentiation, and thus to obtain cells 
positive to Glial Fibrillar Acidic Protein (GFAP), a marker of astrocytes and to β3 tubulin, 
that is specifically expressed in mature neurons.  
α1 tubulin-GFP cells were transfected with a single shRNA and, after selection with 
puromycine, pool of clones were seeded in monolayer in NDM. The readout of the 
screening was the detection by eye at microscope of EGFP expression that was monitored 
at day 4, 7 and 10 of differentiation. The differentiation conditions used are very powerful 
to study the impact of a single gene avoiding extrinsic influences and not reproducible 
effects due to serum. We speculated that a gene whose knock-down by RNA interference 
affects the generation of neurons may be involved not only in differentiation but also in 
maintenance of self-renewal and pluripotent status. Thus, we focused our attention on 
genes whose knock-down impaired EGFP expression and, in turn, neuronal differentiation. 
Indeed, we selected genes with a strong effect on EGFP signal and then we confirmed 
these results in three rounds of transfection. To date, we have screened about 10500 genes 
and more than 30000 shRNA constructs. As a result of the first part of the screening we 
found 50 genes whose knock-down affects ES cell differentiation. In 2008 we published a 
paper where we characterized one of these 50 genes, the transcription factor Klf5, as a key 
factor involved in ES cell self-renewal through the regulation of Oct3/4 and Nanog 
expression (Parisi, Passaro et al. 2008). Among the 50 genes selected, we found 6 
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uncharacterized and unpublished genes (table1). Among these 6 genes we selected for 
further studies the riken cDNA 4632428N05, that we named Dies1 (Differentiation of ES 
cell 1), given its effect on ES cell differentiation (Fig. 8)  
 
TABLE 1:  LIST OF UNCHARACTERIZED GENES WHOSE KNOCK-DOWN 
AFFECTS NEURONAL DIFFERENTIATION 
 
Riken cDNA 4632428N05 Riken cDNA E130310K16 
Riken cDNA 4632404H12 Riken cDNA 4921522P10 
Riken cDNA 4933412D19 Riken cDNA 4833418A01 
 
 
 
FIGURE 8:  RIKEN cDNA 4632428N05 (NAMED DIES1) SUPPRESSION BY 
RNA INTERFERENCE AFFECTS ES CELL DIFFERENTIATION INTO NEURONS 
 
 
 
α1-tub GFP cells, transfected with NS shRNA or with Dies1 shRNA, were cultured 13 days in neural 
differentiation medium. EGFP expression is driven by the neuronal specific promoter α1 tubulin. 
 
 
 
 
 
 
 37
Dies1 suppression impairs ES cell differentiation into neurons 
 
First of all, we attempted to confirm results obtained in α1 tubulin-GFP cells. To this aim, 
we transfected mouse embryonic stem cell line, E14 tg2A, with the shRNA targeting Dies1 
available in the library (sh1). This shRNA is able to reduce Dies1 mRNA level to 40-50% 
(Fig. 9). Pools of clones stably expressing Dies1 KD1 (Dies1 KD1 cells) were cultured in 
neural differentiation medium (NDM). At day 13 of differentiation we stained β3 tubulin 
as marker of mature neurons. As shown in Fig. 10, the number of neurons is strongly 
reduced in Dies1 KD1 cells compared to cells transfected with non-silencing shRNA 
construct (NS KD). This result confirmed what we observed in α1 tubulin-GFP cells. To 
avoid off target effects, we designed others 3 shRNA targeting Dies1 mRNA. One of them, 
targeting 3’UTR of Dies1 mRNA (sh2), is efficient in silencing Dies1 mRNA as well as 
Dies1 KD1 (Fig. 9). We performed the same experiment described above with cells stably 
expressing Dies1 shRNA2. As expected, the staining with β3 tubulin antibody in Dies1 
KD2 cells at day 13 of differentiation displayed the same phenotype obtained in Dies sh1 
cells (not shown). Indeed, about 60% of NS KD cells are positive to β3 tubulin staining at 
day 13 of differentiation compared to less than 30% of Dies1 KD cells (Fig. 11). We noted 
also a reduction in the number of glial cells, suggesting that Dies1 suppression was 
involved not only in neuronal differentiation, but also in glial differentiation. In fact, about 
12% of NS KD cells were stained with the antibody of the astrocyte marker GFAP, 
compared to less than 4% of Dies1 KD cells (Fig. 11). No signs of non-ectodermal 
differentiation were detected in our culture conditions. In fact, only few cells (about 1-3%) 
were stained with the antibody of the endodermal marker HNF3β and no cells were stained 
with antibodies of markers of early mesoderm as Brachyury or of late mesoderm such as 
α-myosin heavy chain (α-MHC) (not shown). Thus, our results indicated that Dies1 
suppression affects ES cell differentiation in both neurons and astrocytes. 
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FIGURE 9:  DIES1 TARGETING SHRNA1 (BLACK) AND SHRNA2 (GREY) 
REDUCE DIES1 mRNA EXPRESSION LEVEL 
 
 
 
 
 
ES cells were transfected with NS shRNA or with shRNA 1 (black) or with shRNA2 (grey) targeting Dies1. 
Real Time PCR analysis was performed to detect Dies1 mRNA levels. Values are reported as fold-changes 
compared to Dies1 mRNA levels in cells transfected with NS shRNA 
 
FIGURE 10:  DIES1 KNOCK-DOWN AFFECTS NEURONAL DIFFERENTIATION, 
REDUCING THE NUMBER OF β3 TUBULIN POSITIVE CELLS 
 
 
 
 
ES cells, transfected with NS shRNA or Dies1 shRNA, were cultured in neural differentiation medium. 
These cells were stained with antibody β3 tubulin at day 13 of differentiation (red). Nuclei were stained in 
blue with Dapi. 
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FIGURE 11: DIES1 KNOCK-DOWN AFFECTS DIFFERENTIATION INTO 
NEURONS AND ASTROCYTES 
 
 
 
S cells, transfected with NS shRNA or with Dies1 shRNAs were cultured in neural differentiation medium. 
These cells were stained at day 13 of differentiation with the following antibodies: β3 tubulin as marker of 
E
neurons, GFAP as marker of astrocytes and HNF3β as marker of the endodermal layer. The number of cells 
positive to these markers was counted in 7 different fields and reported in graph as percentage of total cells, 
which were stained with Dapi. This experiment was performed in triplicate. 
**, p<0,001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 40
Dies1 suppression impairs ES cell differentiation into cardiomyocytes 
iven its effect on differentiation into neurons and astrocytes, we asked whether  Dies1 
IGURE 12:  DIES1 KNOCK-DOWN AFFECTS PROPER DIFFERENTIATION 
INTO CARDIOMYOCYTES 
 
 
 
S cells, transfected with NS shRN A1 (grey), were cultured as Embryoid 
odies (EBs) with hanging dro  8 of differentiation the EBs containing 
 
G
suppression by RNA interference affected specifically neural differentiation. To answer 
this question we cultured Dies1 KD cells as Embryoid Bodies (EBs) with hanging drop 
differentiation method. When ES cells are differentiated as EBs with hanging drop 
differentiation, they form all three germ layers and every EB contains one or more beating 
hearts if cultured in cardiomyocytes differentiation medium (CDM). CDM contains 
GMEM supplemented with an empirically selected FBS serum. Every EB contains one or 
more beating hearts after 7-9 days in CDM, whereas 12 days are required to obtain 
completely differentiated cardiomyocytes. As shown in Fig. 13, Dies1 KD cells cultured as 
Embryoid Bodies in CDM gave rise to a lower number of EB containing beating hearts at 
day 8 of differentiation (about 60% compared to 100% of EBs derived from NS shRNA 
cells) (Fig. 12). This result suggested that Dies1 was involved also in differentiation into 
cardiomyocytes, impairing proper differentiation when it is suppressed by RNA 
interference.  
 
F
 
 
 
 
 
 
E A (black) or with Dies1 shRN
p differentiation method. At dayB
beating hearts were counted (total number= 48). The experiment was done in triplicate. 
*,p<0,01 
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Induction of Dies1 expression is an early event of differentiation 
ons, astrocytes and 
IGURE 13: DIES1 EXPRESSION INCREASES DURING DIFFERENTIATION 
S cells were culture es (EBs) with 
anging drop differentiation method. RT Real Time PCR analysis was performed to detect Dies1 mRNA 
IGURE 14: DIES1 EXPRESSION INCREASES IN CONSEQUENCE OF Oct4 
ND Sox2 SUPPRESSION 
Dies1 suppression impaired ES cell differentiation into neur
cardiomyocytes. This data were supported by the increase of Dies1 mRNA expression 
levels when cells were cultured in conditions promoting differentiation (Fig. 13). In 
addition, Dies1 mRNA expression levels increased in cells where Oct4 and Sox2 were 
suppressed by RNA interference, suggesting that the increase of Dies1 expression level is 
an early event of differentiation (Fig. 14). However, the suppression of Nanog did not exert 
any effect on Dies1 expression at early time points. 
 
 
F
 
 
 
 
 
 
 
 
E d in monolayer in neural differentiation medium or as Embryoid Bodi
h
levels at different time points during differentiation. The Dies1 mRNA levels are expressed as fold-changes 
compared to undifferentiated ES cells.  
 
 
F
A
 
 
ES cells were transfected with siRNA targeting Sox2 or Nanog, or with shRNA targeting Oct4. RT-Real 
Time PCR analysis was performed to detect the mRNA expression of Nanog, Sox2, ct4 and Dies1 48 hours O
after transfection. The values are reported as fold-changes compared to control (non silencing si/sh RNA)  
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Dies1 knock-down maintains Alkaline Phosphatase expression in the absence of LIF 
rentiate, thus they remained completely or 
t an alternative differentiation fate, becoming a specific 
1 KD cells in the absence of LIF for 6 days 
 
The results showed before suggested that Dies1 was involved in early steps of ES cell 
differentiation. Dies1 suppression, in fact, impaired ES cell differentiation and exerted its 
effect in different culture conditions. We hypothesized two different fates for ES cells 
where Dies1 is suppressed (Dies1 KD cells): 
1. Dies1 KD cells were unable to diffe
partially undifferentiated. 
2. Dies1 KD cells underwen
lineage. 
To test the first hypothesis, we cultured Dies
and then we stained the marker of undifferentiated state Alkaline Phosphatase (AP) with a 
colorimetric assay (AP assay). As mentioned before, LIF is necessary for maintaining ES 
cell undifferentiated in culture. Thus, the absence of LIF leads to a weak and uncontrolled 
differentiation. ES cells grown without LIF, progressively loose the expression of markers 
of undifferentiated state, such as the transcription factors Oct4 and Nanog and the 
membrane protein AP. The AP assay evaluates the ability of cells to remain 
undifferentiated in the absence of LIF, giving rise to colonies stained in red, if the cells are 
positive to AP staining and thus, still undifferentiated. We speculated that if Dies1 was 
involved in pluripotency or in early steps of differentiation, Dies1 KD cells should 
maintain the expression of undifferentiated even in the absence of LIF. As expected, less 
than 10% of NS KD colonies are positive to AP staining when they are cultured for 6 days 
in the absence of LIF. This result indicated that they underwent proper differentiation, 
loosing the expression of undifferentiated markers in the absence of LIF. On the contrary 
about 60% of Dies1 KD colonies were positive to AP staining, indicating that they 
maintained the expression of undifferentiated markers when they are cultured without LIF 
(Fig. 15). Thus, Dies1 KD cells were, at least in part, not dependent on LIF for maintaining 
undifferentiated state.  
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FIGURE 15:  DIES1 KNOCK-DOWN MAINTAINS ALKALINE PHOSPATASE 
XPRESSION IN THE ABSENCE OF LIF E
 
 
 
 
 
S cells, transfected with NS shRN ultured in the absence of LIF. At day 6, 
lkaline Phosphatase (AP) was used as marker of the undifferentiated state. The number of colonies (red) 
 
 
A and Dies1 shRNA1, were c
 
 
 
 
 
 
E
A
positive to AP present in a 10 cm dish was counted and reported as percentage compared to colonies positive 
to AP when cells are cultured in presence of LIF. The experiment was done in triplicate.  
*, p<0,01 
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Dies1 suppression maintains the expression of undifferentiated markers in conditions 
promoting differentiation 
iven that Dies1 KD cells maintained, at least in part, Alkaline Phosphatase (AP) 
lls grown 
 demonstrated that Dies1 KD cells were unable to differentiate 
 
G
expression when the cells were grown in the absence of LIF we investigated if AP 
expression was maintained also when Dies1 KD cells were grown in neural differentiation 
medium (NDM). To this aim, we stained AP in Dies1 KD cells cultured 7 days with NDM. 
In this case, it was not easy to count the number of cells positive to AP, because they are 
not seeded at clonal density. However, the results obtained (Fig. 16) encouraged us to 
explore further in detail the expression of undifferentiated markers in Dies1 KD cells 
grown in conditions promoting differentiation. To this aim, we stained Oct4 and Nanog as 
marker of undifferentiated state at day 13 in NDM. Indeed, in NS KD cells Oct4 and 
Nanog were undetectable at day 13 of neural differentiation whereas Dies1 KD cells 
formed many clusters of cells positive to Oct4 and Nanog staining, retaining ES-cell like 
morphology (Fig. 17 A). To confirm this result, we measured Oct4 and Nanog mRNA 
expression levels (Fig. 17 B). No changes in Oct4 and Nanog expression levels between 
NS KD and Dies1 KD cells were detected in undifferentiated cells. On the contrary, in NS 
KD cells Oct4 and Nanog expression strongly decreased during differentiation becoming 
almost undetectable, whereas in Dies1 KD cells their expression was significantly higher 
than in controls at day 7 and increased at day 13, suggesting that the fraction of cells still 
expressing Oct4 and Nanog was still proliferating. In addition, Oct4/Nanog positive cells 
expressed also other markers of undifferentiated state, as E-cadherin (Fig. 17 C). 
The persistence of undifferentiated markers was further explored in Dies1 KD ce
in conditions promoting differentiation into cardiomyocytes. To this aim, Oct4 and Nanog 
were stained in EBs derived from Dies1 KD cells grown in cardiomyocytes differentiation 
medium for 8 days. Indeed, in EBs derived from NS KD cells Oct4 and Nanog expression 
was restricted to a small area whereas they were widely expressed in EBs derived from 
Dies1 KD cells (Fig. 17 D). 
Taken together, these results
retaining undifferentiated features such as Oct4, Nanog and AP expression when they were 
cultured in conditions promoting differentiation.   
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FIGURE 16:  DIES1 KNOCK-DOWN MAINTAINS ALKALINE PHOSPHATASE 
EXPRESSION IN CONDITIONS PROMOTING NEURAL DIFFERENTIATION  
)  AP staining in 10 cm dish 
 shRNA             Dies1 shRNA 
ES cells, transfected with ditions promoting neural 
ifferentiation. At day 6, Alkaline Phosphatase was stained in red. 
)  Detail of colonies stained with Alkaline Phosphatase assay 
ies1 shRNA 
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FIGURE 17: DIES1 KNOCK-DOWN MAINTAINS THE EXPRESSION OF 
NDIFFERENTIATED MARKERS IN CONDITIONS PROMOTING 
 (KD) cells form many colonies positive to Oct4 and Nanog 
taining in conditions promoting neural differentiation 
S KD  
api                                             Oct4                                           Nanog 
ies1 KD 
i                                              Oct4                                            Nanog 
 
S cells, transfected with NS shRNA or Dies1 shRNA, were cultured in conditions promoting neural 
ifferentiation. At day 13 of differentiation Oct4 (red) and Nanog were stained. Nuclei were stained with 
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B) Dies1 KD cells maintain higher Oct4 and Nanog mRNA expression levels than 
ontrols in conditions promoting neural differentiation  
S cells, tran g neural 
ifferentiation. Real Time PCR analysis was performed to detect Oct4 and Nanog mRNA expression in 
) Dies1 KD cells, which are still positive to Oct4 in conditions promoting neural 
ifferentiation, co-express the undifferentiated marker E-cadherin 
 
S cells transfected with Dies1 shRNA, were cultured in conditions promoting neural differentiation. At day 
3 of differentiation these cells were stained with Oct4 and E-cadherin antibodies. Nuclei were stained in 
 
c
 
 
 
 
 
 
E
d
sfected with NS shRNA or Dies1 shRNAs, were cultured in conditions promotin
undifferentiated conditions (day 0) and at day 7 and 13 of differentiation. The values are reported as 
percentage relative to Oct4 and Nanog expression in undifferentiated cells transfected with NS shRNA. 
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D) Dies1 KD Embryoid Bodies maintain wide Oct4 and Nanog expression  
S KD Embryoid Bodies 
          
             Dapi                            Oct4                           Nanog 
IES1 KD Embryoid Bodies 
             Oct4                           Nanog 
 
 
S cells, tran es with hanging drop 
ifferentiation method in cardiomyocytes medium. At day 8 of differentiation Oct4 (red) and Nanog (green) 
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Dies1 re-expression rescues Dies1 knock-down effect 
o be sure that Dies1 was responsible for Dies1 knock-down effect on ES cell 
were unable to undergo proper differentiation, 
 
T
differentiation, we performed a “rescue” experiment. We transfected Dies1 coding cDNA 
in ES cells stably expressing Dies1 shRNA2 (Dies1 KD2 cells). The shRNA2 targets Dies1 
3’UTR, thus not affecting the expression of Dies1 coding cDNA expression. We tested the 
ability of exogenous Dies1 to rescue the effect of the suppression of endogenous Dies1. As 
mentioned before, Dies1 suppression led to maintenance of the expression of the 
undifferentiated markers in conditions promoting differentiation. This effect indicated that 
Dies1 KD cells were not able to properly differentiate. To explore the ability of Dies1 re-
expression to rescue Dies1 knock-down we measured Oct4 expression in “rescued” cells. 
As shown in figure 18  Dies1 over-expression did not modify Oct4 expression levels in NS 
KD cells at day 0 (when they are undifferentiated) compared to NS KD cells transfected 
with an empty vector (NS KD mock). In parallel, Dies1 transfection in Dies1 KD2 cells 
had no effect on Oct4 expression at day 0, compared to the transfection with an empty 
vector (Dies1 KD2 mock). Thus, when cells were grown in undifferentiated condition no 
difference in Oct4 expression occurred .  
As mentioned before, Dies1 KD cells 
maintaining the expression of undifferentiated markers. As expected, at day 3 of 
differentiation, Dies1 KD2 mock transfected cells exhibited higher Oct4 expression than 
NS KD mock transfected cells. However, at day 3 of differentiation Dies1 transfection did 
not affect Oct4 expression in NS KD cells compared to NS KD mock transfected cells. On 
the contrary, Oct4 expression levels were strongly reduced in Dies1 KD2 cells transfected 
with Dies1 compared to Dies1 KD2 mock transfected cells. This phenomenon resulted in 
restoring Oct4 expression to levels very similar, if not identical, to controls. As a 
consequence of Oct4 proper expression in the “rescued” cells, we may conclude that Dies1 
re-expression was able to restore proper differentiation ability in cells where endogenous 
Dies1 is suppressed by RNA interference. 
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FIGURE 18:  DIES1 RE-EXPRESSION “RESCUES” DIES1 KNOCK-DOWN 
FFECT ON NEURAL DIFFERENTIATION, RESTORING PROPER OCT4 
)  Real Time RT PCR analysis of Oct4 mRNA levels  
E
EXPRESSION 
 
A
 
 
) Western Blot analysis of Oct4 protein levels B
 
 
 
Real Time PCR (A) or Western Blot (B) analysis was performed to detect Oct4 expression levels. In the 
anel A Oct4 expression was analysed in undifferentiated conditions and at day 3 of differentiation, whereas p
the panel B Oct4 protein expression level was analysed at day 3 of differentiation. 
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Dies1 knock-down affects ES cell developmental potential in vivo 
o investigate the effect of Dies1 suppression in vivo, we tested the ability of Dies1 knock-
 
T
down cells to form teratoma. As mentioned before, ES cells are able to give rise to 
teratoma when they are injected subcutaneously into nude mice. Stemness and 
tumorigenesis, in fact, are strictly linked each other. We transfected ES cells with NS 
shRNA (NS KD cells) or with Dies1 shRNA  (Dies1 KD cells) and then cultured the cells 
with puromycin for 6 days. A pool of stable clones where Dies1 was strongly down 
regulated was selected and then injected subcutaneously into 3 SCID mice (NS KD cells 
on the right flank and Dies1 KD cells on the left flank). After 3 weeks we explanted tumors 
from animals. As shown in the figure 19A, the tumors formed by Dies1 KD cells were 
smaller than the controls. This result suggested that a consistent fraction of Dies1 KD cells 
lost proper differentiation ability, giving rise to a small tumor, confirming the result 
obtained in vitro. Indeed, more than 50% of cells were shown to be unable to differentiate 
in vitro, thus explaining the reduced size of the tumors in vivo. However, the tumors 
derived by Dies1 KD cells were formed many different cell types, as typically occurs in 
teratoma. This result suggested that the fraction of cells  still able to differentiate as it gave 
rise to  teratoma without any clear histological difference even if the size was decreased 
(Fig. 19 B). Thus, Dies1 suppression affected ES cell pluripotency as in vivo as in vitro. 
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FIGURE 19: DIES1 KNOCK-DOWN AFFECTS ES CELL DEVELOPMENTAL 
POTENTIAL IN VIVO 
)  Dies1 KD decreases the size of the teratomas 
S KD and Dies1 KD cell rs were explanted after 3 weeks. The 
gure represents an example of the explanted teratomas. 
)  Histological analysis of teratomas 
 
eratomas deriving from NS KD and Dies1 KD cells were fixed in PFA and embedded 
to paraffin. Then they were coloured with haematoxylin and eosine 
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Dies1 is expressed in blastocyst, in ES cells and in some adult organs  
od) in mouse ES 
IGURE 20: DIES1 IS EXPRESSED IN MOUSE ES CELL AND BLASTOCYST 
S cells were transfected with NS s e 2). HEK 293 cells were 
fected with Dies1 cDNA (lane 3) as control. Western Blot analysis with Dies1 antibody 11375 was 
Western blot analysis with Dies1 antibody 11375 (see material and meth
cells identified a specific band whose molecular weight is about 60 kilodalton, suggesting 
strong post-translational modifications as the expected size of Dies1 protein is 35 KD. An 
aspecific band, whose molecular weight is about 30 KD, was present in mouse ES cells 
total extract and was recognized by pre-immune serum also (not shown). The band of 60 
kilodalton disappears in ES cells total extracts after the transfection of the shRNA targeting 
Dies1 (Fig. 20 A). As further control, we also transfected Dies1 cDNA in HEK 293 and 
detected a band of a bit higher molecular weight because of the presence of the 3xFLAG 
tag. To confirm the expression of Dies1 in vivo we stained mouse blastocysts with 
antibody 11375 (Fig. 20 B). The staining with serum 11375 showed signals on the surface 
of some cells in the blastocyst. Then we asked if Dies1 is expressed in mouse adult. To this 
aim we performed Real Time PCR analysis. This analysis indicated that Dies1 is strongly 
expressed in lung, spleen and bone and is detectable in others organs such as brain, testis 
heart and liver even if at lower level (Fig. 21 A), as suggested also by data available in 
databases of ESTs (Unigene). The strong expression in lung and spleen was confirmed by 
Western Blot analysis with Dies1 antibody (Fig. 21 B). The band of higher molecular 
weight detected in brain and testis could be the result of different post-translational 
modifications and needs to be confirmed as a specific Dies1 signal. 
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B) Confocal microscopy images of blastocyst 
ouse blastocysts (E 3,5) were fixed and incubated with pre-immune serum (green) or with Dies1 antibody 
1375 (green). Nuclei were stained with Dapi (blue). 
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FIGURE 21: DIES1 EXPRESSION IN ADULT MOUSE ORGANS 
A)  Dies1 mRNA expression levels 
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and liver (lane 7). HEK 293 cells were transfected with Dies1 cDNA HA tagged  as control 
(lane 8). 
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Dies1 is a surface protein 
o investigate Dies1 function we performed an in silico analysis of Dies1 sequence that is 
surface, Dies1 contains an Ig-like domain. As Ig-like 
 
T
available on Ensembl database. As shown Fig. 22A, Dies1 protein consists of 314 
aminoacids (aa). The sequence of aa 1-32 is a typical signal peptide and the aa 192-213 
consists of a putative trans-membrane tract. This observation suggested a possible 
localization in membrane. Of great concern is the presence of an Ig-like domain in the N-
terminal part of the protein (the putative extra-cellular/extra luminal part). Ig-like domains 
are involved in protein-protein interaction and can be commonly found in proteins whose 
function is adhesion, as cadherins and receptor activity such as EGFR, PDGFR and other 
related proteins. To confirm bioinformatics prediction we performed an immuno-staining 
in mouse ES cells and in HEK 293 over-expressing Dies1 full-length protein fused with 
3xFLAG tag at C-terminus of the protein. The cells were fixed, permeabilyzed and 
incubated with FLAG antibody. Confocal images showed that Dies1 was expressed on cell 
surface, supporting bioinformatics prediction (Fig. 22B). Moreover, the staining resulted 
also in signals present in intracellular vessels suggesting trafficking from endoplasmic 
reticulum to surface and vice versa.  
As many proteins expressed on cells 
domains are commonly glycosylated, we tested if Dies1 was glycosylated in ES cells. 
Dies1, in fact, contains at least 3 putative sites of N-glycosylation at the N-terminal part of 
the protein. To this aim, we treated ES cells over-expressing Dies1 fused to 3xFLAG tag 
with tunicamycin, an N-glycosylation inhibitor, at different concentrations for 24 hours. 
Western blot analysis with FLAG antibody resulted in a strong change of Dies1 
electrophoretic mobility. This is dose-dependent and at high concentrations of tunicamycin 
the electrophorectic mobility become very close to the expected size of the protein, 35 
kilodalton (Fig. 22 C). This result indicated that Dies1 was N-glycosylated and this post-
translational modifications could be responsible for its electrophorectic migration around 
60 kilodalton.  
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FIGURE 22: DIES1 IS A SURFACE PROTEIN 
A) Dies1 sequence 
 
In italic the signal peptide (aa 1-32). Underlined the transmembrane domain (192-213). In bold putative sites 
for N-glycosylation. 
 
B) Dies1-3XFLAG (red) is expressed on ES cell surface 
 
C) Dies1-3XFLAG (green) is expressed on HEK 293 cell surface 
 
Confocal images of ES cells (40X magnification) (B) and HEK 293 (63X magnification) (C), transfected 
with Dies1 fused to 3xFLAG were stained with FLAG antibody 
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ES cells transfected with Dies1-3xFLAG were incubated for 24 hours with DMSO or with 
the inhibitor of N-glycosylation tunicamycin at different concentrations. Western Blot 
analysis was performed with FLAG antibody to analyse Dies1 electrophoretic mobility.   
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Dies1 extra-cellular domain plays a crucial role for Dies1 function 
 
As Dies1 knock-down has a strong impact on ES cell differentiation we investigated the 
effect of Dies1 over-expression. Dies1 full-length (f.l.) over-expression in undifferentiated 
cells did not affect the expression of markers of undifferentiated state such as Oct4, Sox2 
and Nanog and proliferation (not shown). Moreover, Dies f.l. cells were able to efficiently 
differentiate in neural differentiation medium and did not show any difference in Alkaline 
Phosphatase (AP) staining compared to mock transfected cells (control) if grown with or 
without LIF for 6 days. Thus, Dies1 f.l. over-expression did not display any clear and 
relevant effect on ES cells. 
As Dies1 is a surface protein, its extra-cellular domain (ECD) should play an important 
role. Moreover, Dies1-ECD contains an Ig-like domain which is usually required for 
binding to interactors. Thus, Dies1-ECD should be crucial for Dies1 proper function. To 
evaluate Dies1-ECD role, we expressed only Dies1-ECD (aa 39-168) fused to 3xFLAG tag 
in HEK 293 and in ES cells. First of all we evaluated Dies1-ECD expression in ES cells 
staining Dies1-ECD cells with FLAG antibody (Fig. 23 A). Then, Western Blot analysis of 
HEK 293 lysates and conditioned medium confirmed that Dies1-ECD was properly 
expressed and secreted in the conditioned medium (Fig. 23 B). We speculated that the 
expression of Dies1-ECD alone may work as a Dies1 dominant negative form: it may 
compete with endogenous full-length Dies1 for binding to interactors inside and outside 
the cell. To test this hypothesis, we transfected Dies1-ECD in mouse ES cells and tested its 
effect on self-renewal and differentiation. In undifferentiated cells, Dies ECD has no effect 
on proliferation and on the expression of undifferentiated state markers such as Oct4, 
Nanog and Sox2, as well as Dies1 f.l. over-expression (not shown). On the contrary, 
Dies1-ECD exerted a clear effect when cells are cultured in the absence of LIF. Indeed, 
Dies1-ECD led to the maintenance of AP expression in about 40% of colonies when cells 
are cultured 6 days without LIF (Fig. 24 A). This result has to be compared to the 
percentage of colonies that maintain AP expression in the controls (less than 10%) and 
after Dies1 f.l. over-expression (about 15%). This confirmed that Dies1-ECD worked as 
Dies1 dominant negative form, resembling Dies1 KD effect. As mentioned before, also 
Dies1 suppression by RNA interference led to maintenance of AP expression, even if its 
effect is stronger than Dies1-ECD resulting in 60% of colonies positive to AP staining. The 
effect of Dies1-ECD in the maintenance of undifferentiated markers was confirmed by the 
increase of Oct4 expression levels in Dies1-ECD cells at day 6 without LIF (Fig. 24 B/C). 
No differences were seen in Nanog expression that continues to be very low in both cases. 
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Further in detail, we analysed Dies1-ECD colonies when the cells were grown in the 
absence of LIF. Dies1-ECD cells formed bigger colonies and showed stronger Oct4 
expression than controls, confirming previous results (Fig. 24 D). 
On the other hand, Dies1-ECD cells were able to differentiate as well as controls in neural 
differentiation conditions, suggesting that others mechanisms may overcome Dies1-ECD 
dominant negative effect in particular contests. 
Given the fact that Dies1-ECD cells maintained, at least in part, AP expression and 
markers of undifferentiated state as Oct4 when ES cells were cultured in the absence of 
LIF we speculated that Dies1-ECD may be used as soluble protein instead of LIF to 
supplement ES cell growth medium. To test this hypothesis we tried two different 
approaches: 
 
1. We purified Dies1-ECD fused to 3xFLAG  from HEK 293 conditioned medium, 
using anti-FLAG resine and added this protein to growth medium (not 
supplemented by LIF); 
2. We supplemented normal ES cell medium (without LIF) with conditioned medium 
of mouse ES clones stably expressing Dies1-ECD fused to 3xFLAG  
 
We cultured ES cells for 6 days in the absence of LIF to perform AP assay. In both cases, 
there was no difference in AP staining compared to controls. This result could be explained 
in different ways:   
1.   There were some technical problems in protein purification from 293 medium and 
in concentration of conditioned medium of ES stable clones; 
2. The amount of protein added to growth medium is too low to exert any effect;  
3. Dies1-ECD binds to Dies1 intracellular interactors, exerting its effect inside the 
cells. Thus, Dies1-ECD is not able to work as soluble protein. 
 
If the last hypothesis is correct, Dies1-ECD should impair the formation of a complex 
whose proper assembly is essential for the function of Dies1 and its partners. Thus, it 
should work as a dominant negative form inside the cells, for example in vescicles, 
impairing the proper assembly of a receptor complex.  
Taken together these results supported that Dies1-ECD plays a very important role and 
shed light on possible Dies1 function as surface receptor.  
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FIGURE 23:  DIES1 EXTRA-CELLULAR DOMAIN (ECD) EXPRESSION 
A)  Dies1-ECD expression in ES cells 
 
 
 
 
 
 
 
ES cells were transfected with Dies1-ECD fused to 3XFLAG. After 48 hours cells were stained with FLAG 
antibody (red) and then analyzed at confocal microscope. 
 
B) Dies1-ECD is properly secreted in culture medium when transfected alone 
 
 
HEK 293 cells were transfected with Dies1 extra-cellular domain (ECD) fused to 3XFLAG. Western Blot 
analysis with FLAG antibody was performed on cell lysate and on conditioned medium. 
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FIGURE 24:  Dies1-ECD MAINTAINS OCT4 AND ALKALINE PHOSPHATASE 
(AP) EXPRESSION IN THE ABSENCE OF LIF 
 
A)  Dies1-ECD maintains AP expression in the absence of LIF 
 
 
 
 
ES cells, transfected with Dies1 full-length or Dies1 extra cellular domain (ECD) were cultured in the 
absence of LIF.  Dies1-ECD maintains AP expression at day 6 in the absence of LIF in more than 30% of 
colonies. Dies1 full-length has no significant effect compared to control (mock transfected cells) 
*, p<0,01 
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B)  Oct4 mRNA expression level in the absence of LIF 
 
 
 
 
 
 
 
ES cells, transfected with an empty vector (mock) or with Dies1-ECD, were cultured in the absence of LIF. 
RT Real Time PCR analysis was performed to detect Oct4 mRNA expression in undifferentiated conditions 
(day 0) and at day 6 in the absence of LIF. The values are reported as percentage of Oct3/4 expression 
compared to cells transfected with empty vector (mock) in undifferentiated conditions (time 0). 
 
C)  Oct4 protein expressionlevel  in the absence of LIF 
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ES cells, transfected with an empty vector (mock), with Dies1-ECD or with Dies1 full-length were cultured 
in the absence of LIF. Western Blot analysis was performed to detect Oct4 expression at day 6 in the absence 
of LIF. 
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D)  Staining of Dies1 ECD colonies in the absence of LIF 
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ES cells, transfected with an empty vector (D) or with Dies1-ECD (E) were cultured without LIF. At day 6 
Oct4 (red) and Nanog (green) were stained. Nuclei were stained in blue with Dapi. 
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Dies1 knock-down affects BMP4 signaling pathway 
As many receptors are tyrosine-phosphorylated, we tested whether Dies1 also was 
phosphorylated in tyrosine. Dies1, in fact, contains two tyrosine residues in the C-terminal 
of the protein. To this aim we transfected HEK 293 with Dies1 cDNA fused to HA tag. 
Western Blot analysis of immunoprecipitation experiments with HA antibody and with p-
Tyr antibody demonstrated that Dies1 was phosphorylated (Fig. 25).  
 
FIGURE 25:  DIES1 IS PHOSPHORYLATED IN TYROSINE 
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HEK 293 cells were transfected with Dies1 full-length fused to HA tag or with an empty vector (control). In 
this first panel Western Blot (WB) analysis with HA antibody was performed. In the second panel, 
immunoprecipitation (IP) with pTyr antibody and then WB with HA antibody were performed. In the third 
panel, IP with HA antibody and WB with pTyr antibody were performed. 
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Given the possible role for Dies1 as a receptor we speculated that Dies1 knock-down (KD) 
or the expression of the extra-cellular domain (ECD) may affect some signalling pathway 
required for proper ES cell developmental potential. Dies1 KD cells, in fact, were unable 
to differentiate in different culture conditions and were at least in part independent by LIF. 
As mentioned before, mouse ES cells are sensitive to extrinsic signals in culture and proper 
signal transduction machinery is required for maintaining ES cell pluripotency. Thus, we 
hypothesized that the alteration of some signalling pathway due to Dies1 knock-down 
resulted in the impaired ability of ES cells to properly differentiate. To address this point, 
we focused on LIF and BMP4 pathways, that are the most important pathways involved in 
the maintenance of self-renewal and pluripotency (Ying, Nichols et al. 2003). To this aim, 
we analysed the expression of genes directly controlled by LIF and BMP4, comparing their 
mRNA expression levels in non-silencing knock-down cells (NS KD) or Dies1 KD cells, 
cultured in undifferentiated conditions. Dies1 suppression did not affect proliferation (Fig. 
26) or the expression of markers of undifferentiated state such as Oct4, Nanog, Sox2 and 
Rex1 when cells were cultured in undifferentiated conditions (Fig. 27A). Moreover, Dies1 
KD cells may be cultured as wild type cells for long periods and did not show any clear 
morphological difference. In addition, LIF targets such as STAT3 (also target of Wnts) and 
Kruppel-like factors such as Klf2, Klf4 and Klf5 were not affected by Dies1 suppression. 
On the contrary Id1, Id2 and Id3 expression was affected by Dies1 suppression (Fig. 27B). 
Ids 1-3 are direct transcriptional targets of SMAD1/5/8-SMAD4 complex that is activated 
by BMP4. To confirm that reduction of Id1-3 expression levels was direct consequence of 
impairment in transducing BMP4 signal, we performed a luciferase assay. To this aim, we 
transfected mouse ES cells with a vector encoding for luciferase under the control of the 
BMP responsive element of Id1 promoter (Id1 BRE luc) (ten Dijke, Korchynskyi et al. 
2003). Mouse ES cells were transiently transfected with Id1 BRE luc and with siRNA non 
silencing or with siRNA targeting Dies1. To minimize effects due to serum, ES cells were 
cultured in GMEM supplemented with Knock-Out serum supplemented by LIF. As shown 
in Fig. 27C, BMP4 treatment (20 ng/ml) for 24 hours, resulted in an increases up to 25 
times of luciferase activity in NS siRNA cells compared to an increase up to 16 times in 
Dies1 siRNA cells. This supported that BMP4 signaling was directly affected by Dies1 
suppression. To investigate whether the reduction of Id 1-3 expression levels was 
dependent on a decreased activity of SMAD 1/5/8 complex, we analyzed the amount of 
phosphorylated and, thus, active, SMAD 1/5/8. As previously described, SMAD 1/5/8 
proteins are phosphorylated and thus, activated, by type I receptors upon BMP4 binding. 
The active, phosphorylated form of SMADs translocates to the nucleus in association with 
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SMAD4, activating or repressing their target genes. As shown in Fig. 27D in Dies1 KD 
cells grown in undifferentiated conditions, the amount of SMAD1-5-8 phosphorylated was 
decreased, whereas total SMAD1 protein level was identical to controls. These results 
indicated that Dies1 KD impaired BMP4 signaling cascade, down-regulating Id1-3 in a 
SMAD dependent manner. 
 
 
 
 
FIGURE 26: DIES1 KNOCK-DOWN DOES NOT AFFECT PROLIFERATION IN 
UNDIFFERENTIATED CONDITIONS  
 
 
Channels (PI-A)
0 50 100 150 200 250
Nu
mb
er
0
50
10
0
15
0
20
0
control               
cells
Channels (PI-A)
0 50 100 150 200
Nu
mb
e
r
0
50
10
0
15
0
20
0 
 
 
 
 
 
ES cells were transfected with NS shRNA (control) or with Dies1 shRNA. Then FACS analysis was 
performed to determine the number of cells in the different phases of cell cycle. 
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FIGURE 27: DIES1 KNOCK-DOWN DOES NOT AFFECT THE EXPRESSION OF 
STEMNESS MARKERS IN UNDIFFERENTIATED CONDITION, WHEREAS IT 
IMPAIRS PROPER BMP4 SIGNALING 
 
 
A) Undifferentiated markers and LIF targets are not affected by Dies1 knock-down 
 
 
 
 
ES cells were transfected with NS shRNA or Dies1 shRNAs. Real Time PCR analysis was performed to 
detect the expression of undifferentiated markers and LIF targets. The values are reported as fold-changes 
compared to cells transfected with NS shRNA. 
 
 
B) BMP4 targets are down-regulated in Dies1 knock-down cells 
 
 
 
 
ES cells were transfected with NS shRNA or Dies1 shRNAs. Real Time PCR analysis was performed to 
detect the expression of BMP direct targets such as Id 1/2/3. The values are reported as fold-changes 
compared to cells transfected with NS shRNA. 
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C) Dies1 knock-down reduces luciferase activity in response to BMP4 treatment 
 
 
 
 
ES cells were transfected with a vector in which luciferase gene is under the control of the BMP responsive 
element of Id1 gene promoter (Id1 BRE LUC). These cells were transfected also with siRNA non silencing 
or with siRNA targeting Dies1 and then grown in knock-out serum supplemented by LIF. 16 hours after 
transfection, the growth medium was supplemented with BMP4 (20 ng/ml) for 24 hours. The values are 
reported as fold-changes compared to luciferase activity (normalized with Renilla) compared to cells 
transfected with siRNA non silencing cultured in the absence of BMP4. 
 
 
 
 
D) SMAD 1/5/8 phosphorylation is reduced in Dies1 knock-down cells 
 
 
 
 
ES cells were transfected with NS shRNA or with Dies1 shRNA. Western Blot analysis was performed to 
detect the phosphorylated and thus active form of Smad 1/5/8. Total amount of  Smad1 protein was used to 
normalize the samples 
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Down-regulation of Id genes does not affect ES cell undifferentiated state 
 
Dies1 suppression affects BMP4 signaling, down-regulating Id 1-3 mRNA levels in a 
SMAD dependent manner. As mentioned before, Id 1-3 regulation seems to be crucial for 
sustaining ES cell self-renewal pluripotency. Id 1-3 impairs the expression of pro-neural 
factors, thus maintaining ES cell undifferentiated when the growth medium is 
supplemented only with LIF and BMP4. In addition, Ying and collaborators demonstrated 
that Id over-expression may overcome the absence of BMP4 in the growth medium (Ying, 
Nichols et al. 2003). In our culture conditions, Id expression levels are reduced to 40-50% 
in consequence of Dies1 suppression by RNA interference. Thus, Id expression is 
decreased but not abolished. Of great concern is that Id down-regulation seems to be in 
contrast with the maintenance of undifferentiated markers in conditions promoting 
differentiation due to Dies1 knock-down. One explanation could be that the reduced levels 
of Ids does not affect Ids proper function, thus having no impact on ES cells, in contrast to 
what observed by Ying and Nichols in 2003 when Id 1-3 expression is completely off. This 
hypothesis is supported by the data obtained by Ying and collaborators in 2008 (Ying, 
Wray et al. 2008). They observed that a strong reduction of Id1 protein due to the absence 
of BMP4 in culture does not lead to differentiation when ES cells are cultured just with 
LIF plus two ERK/FGF4 inhibitors. To prove that Id 1-3 down-regulation did not affect ES 
cell self-renewal and pluripotency, we transfected both Id1 and Id3 targeting shRNA in ES 
cells. 2 out of 48 clones screened displayed decreased mRNA levels of both Id1 and Id3. 
These clones did not show any significant difference in the expression of undifferentiated 
markers such as Oct4, Nanog and Sox2 (Fig. 28) and were maintained in culture as well as 
controls at least for 2 weeks. These results strongly supported the hypothesis that Id down-
regulation did not affect ES cell ground state. 
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FIGURE 28:  ID1/ID3 DOWN-REGULATION DOES NOT AFFECT THE 
EXPRESSION OF UNDIFFERENTIATED MARKERS  
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ES cells were transfected with a shRNA targeting Id1 and a shRNA targeting Id3. 24 clones were screened 
and two of them (#6 and # 7) showed reduced mRNA expression of Id1 and Id3 as shown by Real Time PCR 
analysis. In these clones mRNA expression levels of Oct4 and Nanog were analyzed. The values are reported 
as fold-changes compared to cells transfected with NS shRNA. 
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Dies1 knock-down induces the up-regulation of Nodal/Activin targets 
 
Dies1 knock-down affects BMP4 signaling in ES cells, reducing the amount of 
phosphorylated SMAD 1/5/8 and their transcriptional targets such as Inhibitor of 
Differentiation (Ids) 1-3. As mentioned before, BMP4 belongs to TGF-β superfamily 
which includes also Nodal and Activin. Nodal and Activin bind to type I receptors Alk4 
and 7 which phosphorylate and in turn, activate SMAD 2-3. Active SMAD 2-3 form 
complexes with SMAD4 and translocate to the nucleus. Nodal/Activin and BMP4 share 
the common effector SMAD4 that is essential for SMAD 1/5/8 and SMAD 2/3 
transcriptional activity. Moreover, inhibitory SMADs (SMAD 6-7) are able to block 
SMADs signalling cascade dependent on both BMP4 and Nodal/Activin. Thus, BMP4 and 
Nodal/Activin pathways are tightly related each other. Given Dies1 knock-down effect on 
BMP4 signalling, we investigated Dies1 involvement in Nodal/Activin signalling. As 
shown in Fig. 29, Dies1 knock-down increased the mRNA levels of the Nodal/Activin 
targets such as Cripto, and Lefty 1-2. (Fig. 29) On the contrary, Nodal expression, that is 
regulated itself by Nodal, is not affected by Dies1 knock-down. An interesting hypothesis 
was that the alteration of Nodal and Activin pathway could be responsible for the effect of 
Dies1 knock-down on ES cell differentiation. As mentioned before, Nodal/Activin 
pathway controls Nanog expression in human ES cells and maintains mouse ES cell 
undifferentiated when E-cadherin is suppressed by RNA interference (Vallier, Mendjan et 
al. 2009) (Soncin, Mohamet et al. 2009). Thus, increasing evidence suggests that Nodal 
and Activin are important players in maintenance of pluripotency. To investigate whether 
Nodal/Activin are involved in the maintenance of the undifferentiated markers due to 
Dies1 suppression, we inhibited Nodal/Activin activity with the chemical compound SB-
431542. SB-431542 specifically inhibits type I receptor activity dependent on Nodal and 
Activin. We hypothesized that inhibition of Nodal/Activin pathway may rescue Dies1 
effect, restoring proper Alkaline Phosphatase (AP) expression when cells were grown in 
the absence of LIF. The SB-431542 inhibitor was added to normal ES cell growth medium 
for 16 hours and then to the medium without LIF for 2 days. The cells were cultured 
without LIF for 6 days and then analysed for AP expression. As shown in Fig. 30, the 
treatment with SB-431542 did not significantly affect the AP staining in NS KD cells. On 
the other hand, the treatment with SB431542 strongly decreased the number of Dies1 KD 
colonies positive to AP, thus restoring proper differentiation in the absence of LIF. To 
confirm this result we investigated the expression of markers of undifferentiated state in 
NS KD cells and in Dies1 KD cells treated with SB-431542. The treatment with SB-
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431542 did not modify Oct4 and Nanog expression in NS KD cells, whereas it strongly 
decreased their expression levels in Dies1 KD cells at day 6 without LIF. As expected, 
when Dies1 KD cells were treated only with DMSO, the expression level of Oct4 and 
Nanog is much stronger than in controls, whereas the inhibition of Nodal and Activin 
restored proper expression of undifferentiated markers. This result was in agreement with 
that of AP staining. Taken together, these results demonstrated that Nodal and Activin 
activity were required for the maintenance of undifferentiated markers due to Dies1 knock-
down. In fact, the inhibition of Nodal/Activin pathway rescued Dies1 knock-down effect, 
restoring differentiation in the absence of LIF. Thus, our data shed light on the fine 
regulation of Nodal/Activin and BMP4 activity in ES cells that appears to be crucial for the 
maintenance of pluripotency.  
 
 
 
 
 
 
 
FIGURE 29: DIES1 SUPPRESSION INDUCES THE UP-REGULATION OF 
NODAL/ACTIVIN TARGETS 
 
 
 
ES cells were transfected with NS shRNA or Dies1 shRNAs. Real Time PCR analysis was performed to 
detect mRNA expression levels of Nodal, Cripto, Lefty1 and Lefty2. Values are reported as fold-changes 
compared to cells transfected with NS shRNA.  
*, p<0,01 
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FIGURE 30: THE TREATMENT WITH NODAL/ACTIVIN PATHWAY INHIBITOR       
SB-431542 RESCUES DIES1 KNOCK-DOWN EFFECT 
 
 
A) Treatment with SB-431542 restores proper Alkaline Phosphatase expression in 
Dies1 knock-down cultured in the absence of LIF 
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ES cells transfected with NS shRNA or Dies1shRNA were cultured in the absence of LIF with DMSO or 
Nodal/Activin inhibitor SB431542. At day 6 Alkaline Phosphatase (AP) was stained and the number of AP 
positive colonies were counted.  
*, p<0,01 
 
 
 
 
B) Treatment with SB-431542 restores proper Oct4 and Nanog expression in 
Dies1 knock-down cultured in the absence of LIF 
 
 
 
 
ES cells transfected with NS shRNA or Dies1 shRNA were cultured in the absence of LIF with DMSO or 
Nodal/Activin inhibitor SB431542. Western blot analysis was performed to detect Oct4 and Nanog 
expression at day 6 in the absence of LIF. 
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Dies1 is a component of the BMP4 signaling pathway  
 
Dies1 suppression down-regulates BMP4 signaling and up-regulates Nodal/Activin 
pathway. This result is not surprising, given the balance occurring between BMP4 and 
Nodal/Activin. Dies1 knock-down cells displayed reduced levels of the BMP4 targets Id 1-
3, in a SMAD dependent manner. In addition the response to BMP4 treatment was 
impaired in Dies1 knock-down cells, suggesting a direct involvement of Dies1 in BMP4 
signaling. 
To confirm a direct involvement of Dies1 in BMP4 signaling pathway, we tested Dies1 
effect when BMP4 signaling was affected. To this aim we down-regulated the only BMP-
type I receptor expressed in ES cells, Alk3 (Mishina, Suzuki et al. 1995). 
We used siRNA to down-regulate Alk3 mRNA levels in ES cells (Alk3 KD cells). The 
effect of Alk3 knock-down is very similar to Dies1 knock-down effect. In fact Alk3 KD 
cells showed reduced levels of Id1 and 3 mRNA levels and increased mRNA levels of the 
Nodal/Activin target as Lefty1. Dies1 suppression in Alk3 KD cells did not exert any 
significant effect compared to Dies1 and Alk3 knock-down  alone, thus suggesting that 
Dies1 and Alk3 are component of the same BMP4-dependent signalling pathway (Fig. 31) 
 
 
FIGURE 31: DIES1 AND ALK3 KNOCK-DOWN RESULTS IN THE SAME 
EFFECT ON THE REGULATION OF TGF-β SUPERFAMILY SIGNALING 
 
 
 
 
ES cells were transfected with siRNA targeting Alk3 and siRNA control. Real time PCR was performed to 
detect mRNA expression levels of Id1, Id3 and Lefty 1. The same experiment was performed in Dies1 
knock-down cells. Dies1 knock-down cells were transfected with siRNA control or with siRNA targeting 
Alk3. All the values are reported as fold-changes compared to cells transfected with siRNA control.  
*, p<0,01 
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To address direct interaction between BMP4 and Dies1 we  performed an ELISA. We 
incubated 96 well plates coated with StrepM antibody with medium harvested by HEK 293 
transfected with Strep-tagged Dies1 extra cellular domain (ECD). As shown before, in fact, 
Dies1-ECD is secreted in the medium and could be harvested in the conditioned medium. 
We refreshed 4 times with new medium and then added BMP4 fluorescently marked with 
europium (Eu-BMP4) As control, we pre incubated some wells with different 
concentrations of non fluorescent BMP4 to perform a competition assay. As shown in Fig. 
32, BMP4 binds to Dies1-ECD, increasing fluorescence signal up to 6 fold compared to 
control (wells incubated with medium harvested by mock transfected HEK 293). The pre-
incubation with BMP4 significantly decreased fluorescent signal in a dose-dependent 
manner. 
 
FIGURE 32: BMP4 BINDS TO DIES1 IN VITRO 
 
 
Conditioned medium harvested from HEK 293 mock-transfected (grey) or transfected with Strep-tagged 
Dies1-ECD (black) was incubated on 96 well plate coated with StrepM antibody. Some wells were pre-
incubated with BMP4 .at reported concentrations Fluorescence was detected with Envision Elisa Reader.  
**, p<0,001 
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Dies1 effect on BMP4 is independent on Nodal/Activin 
 
Our results shed light on a direct involvement of Dies1 in BMP4 signaling. However, we 
could not exclude that the effect on BMP4 signaling was also a consequence of the up-
regulation of Nodal/Activin signalling. To test this hypothesis, we treated mouse ES cells 
with Nodal/Activin inhibitor, SB-431543. This inhibitor specifically blocks the activity of 
type I receptors dependent on TGF-β1, Nodal and Activin but not dependent on BMP4. As 
expected, the treatment of mouse ES cells with SB431542 resulted in the block of SMAD 
2/3 activity. In fact, it resulted in decreasing the expression of  Nodal/Actvin targets as 
Lefty1, to more than 95% in NS KD cells as well as in Dies1 KD cells. In addition, SB-
431542 treatment induced a strong up-regulation of BMP4 targets such as Id1 and Id3 (Fig. 
33), confirming the hypothesis of a strong balance between BMP4 and Nodal/Activin. Of 
great concern is that Id1 and Id3 were increased upon SB-431542 treatment in NS KD cell 
and in Dies1 KD cells but the increase of Ids expression in response to Nodal/Activin 
inhibitor is less in Dies1 KD than in NS KD cells. This indicated that BMP4 signalling is 
affected by Dies1 knock-down even when Nodal/Activin signalling is off, demonstrating 
that Dies1 effect on BMP4 signaling was independent on Nodal/Activin activity.  
 
FIGURE 33:  DIES1 KNOCK-DOWN EFFECT ON BMP4 SIGNALING IS 
INDEPENDENT ON NODAL/ACTIVIN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ES cells, transfected with NS shRNA or Dies1 shRNA were treated with DMSO or with Nodal/Activin 
pathway inhibitor SB-431542. Real Time PCR was performed to detect the mRNA levels of Id1, Id3 (BMP4 
targets) and Lefty1 (Nodal/Activin target). The values are reported as fold-changes compared to levels in NS 
shRNA cells treated with DMSO. 
*, p<0,01 
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Dies1 effect on Nodal and Activin is indirect  
 
Dies1 knock-down up-regulates Nodal/Activin targets in ES cells. This could be due to a 
direct effect of Dies1 on Nodal/Activin or could be consequence of the effect on BMP4 
signaling. To further explore Dies1 knock-down effect on Nodal/Activin signaling we 
transfected ES cells with a construct (CAGA-luc) containing the sequence encoding for 
luciferase driven by the sequence (CAGA) recognized by SMAD 2/3. The treatment with 
Nodal or Activin  increased luciferase activity to 2-3 folds in NS KD cells. The 
suppression of Dies1 by RNA interference did not result in any significant difference in the 
response to Nodal and Activin  compared to NS KD cells (Fig. 34) In addition, Dies1 KD 
cells showed just a weak, if significant, increase in phosphorylation of SMAD 2/3 even if 
the amount of total SMAD 2 is much higher than in controls (Fig. 35). The up-regulation 
of SMAD 2/3 total levels in Dies1 KD cells has to be further explored. Taken together, 
these results suggested that Dies1 effect on Nodal/Activin signalling is indirect. The up-
regulation of Nodal/Activin targets in ES cells due to Dies1 knock-down could be 
consequence of the impairment of BMP4. One hypothesis is that the decreased amount of 
phosphorylation SMAD 1/5/8, could make SMAD 4 more available to SMAD 2/3, 
promoting SMAD 2/3 transcriptional activity.  
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FIGURE 34:  Dies1 knock-down does not exert any effect on Nodal/Activin 
response in luciferase assay 
 
 
 
 
 
 
 
 
 
 
 
 
**
* *
 
 
 
 
ES cells were transfected with a vector which contains luciferase reporter gene. Its expression is  driven by 
the SMAD2/3 responsive sequence. These cells were transfected also with NS siRNA or Dies1 siRNA. 24 
hours after transfection, the growth medium was supplemented with Nodal or Activin. The values are 
reported as relative luciferase activity (normalized with Renilla) compared to untreated NS KD cells. 
*, p<0,01 
 
 
 
 
FIGURE 35:  Dies1 knock-down does not affect SMAD 2/3 phosphorylation even if 
the amount of total SMAD2 is increased  
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ES were transfected with NS shRNA or with Dies1 shRNA. Western blot analysis was performed to detect 
the expression levels of total Smad2 and phosphorylated Smad 2/3. Gapdh was used to normalize the amount 
of protein in the extracts. 
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DISCUSSION 
 
Molecular players involved in mouse ES cell self-renewal and differentiation are still 
largely unknown. The identification of the molecular machinery which controls these 
processes will contribute to better understand ES cell biology and to improve their use for 
regenerative medicine. Here we report the function of a previously uncharacterized gene, 
we named as Dies1 (Differentiation of Embryonic Stem cell 1), given its effect on ES cell 
differentiation. In our laboratory, the screening of a large collection of shRNA constructs 
led to the identification of 50 genes whose knock-down strongly affects ES cell 
differentiation. Among these ones, we focused on Dies1. We confirmed the results of the 
screening with different approaches, demonstrating that ES cells where Dies1 is suppressed 
by RNA interference are unable to properly differentiate into neurons, astrocytes and 
cardiomyocytes. In conditions promoting differentiation, in fact, Dies1 knock-down cells 
maintain the expression of undifferentiated markers such as Oct4, Nanog and Alkaline 
Phosphatase. In addition, Dies1 knock-down cells are, at least in part, independent from 
LIF, maintaining undifferentiated markers when they are cultured in the absence of LIF. 
Dies1 suppression exerts its effect on ES cell differentiation as in vivo as in vitro, giving 
rise to teratomas smaller than controls when Dies1 knock-down cells are injected into nude 
mice. Thus, Dies1 seems to be required for proper ES cell developmental ability. Dies1 is 
also expressed in vivo as shown by the staining of mouse blastocyst with Dies1 antibody, 
supporting the hypothesis that Dies1 plays an important role in ES cells. Immunostaining 
in blastocyst and in ES cell indicates that Dies1 is expressed on cell surface, confirming 
bioinformatics prediction based on the sequence. These in silico analysis suggest that 
Dies1 contains a trans-membrane domain and an Ig-like domain in the putative extra-
cellular part of the protein. Ig-like domains are involved in protein-protein interaction and 
can be found in proteins which play a role in adhesion such as cadherins. Recently, E-
cadherin suppression was shown to maintain ES cell undifferentiated in the absence of LIF, 
exerting the same effect of Dies1 suppression (Soncin, Mohamet et al. 2009)7. However, 
Ig-like domains can be found also in many receptors such as EGFR and PDGFR. As many 
others receptors, Dies1 is glycosylated in N-asparagine residues and is phosphorylated in 
tyrosine. The function of Dies1 as membrane receptor is further supported by the 
observation that Dies1 extra-cellular domain (ECD) works as Dies1 dominant negative 
form, resembling Dies1 suppression effect. ES cells transfected with Dies1-ECD alone 
maintain the expression of undifferentiated markers such as Oct4 and Alkaline 
Phosphatase when they are grown in the absence of LIF. Thus, the suppression of Dies1 or 
the expression of its extra-cellular domain alone, confers LIF independence to ES cells. 
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However, the effect of Dies1-ECD is weaker than Dies1 suppression. Indeed ES cells 
expressing Dies1-ECD are able to properly differentiate into neurons, astrocytes and 
cardiomyocytes. Thus, other mechanisms may overcome the dominant negative effect of 
Dies1 ECD in particular contests. Of great concern is that Dies1 ECD is not able to work 
as soluble protein instead of LIF, suggesting that Dies1 ECD works inside the cell. One 
explanation could be that the expression of Dies1-ECD impairs the formation of a 
complex, whose assembly is necessary for Dies1 proper function. All these results shed 
light on a possible involvement of Dies1 in the signalling pathways controlling ES cell 
pluripotency. ES cells in fact, are strictly dependent on proper transduction of extrinsic 
signals for maintaining self-renewal and pluripotency. Thus, we explored the effect of 
Dies1 suppression on the main signalling pathways governing ES cell biology: LIF and 
BMP4. LIF pathway seems to be unaffected by Dies1 knock-down, whereas the 
transcriptional targets of BMP4 such as Inhibitor of Differentiation (Id) genes are down-
regulated in Dies1 knock-down cells. This down-regulation is Smad-dependent as the 
amount of phosphorylated and thus, active Smad 1/5/8 complex is decreased in Dies1 
knock-down cells. The effect on BMP4 signaling pathway is consequence of a decreased 
response to the BMP4, as suggested by luciferase assays. Among the four BMPs-type I 
receptors which have been identified, Alk3 is the only one expressed in mouse ES cells and 
in the blastocyst. Alk3 knock-out mice exhibit reduced cell proliferation in the epiblast, 
suggesting that Alk3 plays a crucial role in ES cell. One hypothesis to explain Dies1 
knock-down effect on BMP4 signaling is that Dies1 works as Alk3 co-receptor. Some co-
receptors acting within the TGFβ/activin/nodal signal transduction pathways have been 
identified so far, whereas only the member of repulsive guidance molecule (RGM) Dragon 
has been identified as interactor of BMPs-type I receptors. In addition, Dragon is able to 
bind to BMP proteins (Babitt, Zhang et al. 2005). Given these data, it was logical to ask 
whether Dies1 sustains BMP4 signaling, directly interacting with BMP4. ELISA suggests 
that BMP4 binds to Dies1 in vitro, supporting the hypothesis that Dies1 may function as 
Alk3 co-receptors. In addition, it will be interesting to investigate the functional interaction 
between BMPs and Dies1 in other biological contexts. For example, BMPs play an 
important role in the bone, where Dies1 is strongly expressed. However, the identification 
of Dies1 as component of BMP4 signaling pathway, does not explain why Dies1 knock-
down cells are LIF independent and maintain the expression of undifferentiated markers in 
conditions promoting differentiation. BMP4 in fact, exerts its action in combination with 
LIF in maintaining ES cell undifferentiated. Thus, we focused our attention on the balance 
of the signaling within the members of TGF-β superfamily, whose main components are 
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BMPs and TGF-βs/Nodal/Activin. These two members of the TGF-β superfamily share a 
common mediator, SMAD4 that is necessary for signal transduction. Both SMAD 1/5/8 
which are activated by BMPs and SMAD 2/3 which are activated by TGF-βs, Nodal and 
Activin require association with SMAD4 to translocate into the nucleus and to exert their 
transcriptional activity. In addition, BMPs and TGF-βs/Nodal/Activin share common 
mechanisms of regulation, such as the inhibitory Smad 6 and Smad 7, which block both 
signalling pathways. We found that in Dies1 knock-down cells Nodal/Activin targets such 
as Cripto, Lefty1 and Lefty2 are up-regualated. This was not surprisingly, given the tight 
regulation between Nodal/Activin and BMP4. Given recent result supporting the crucial 
role for Nodal and Activin in the control of pluripotency (Soncin, Mohamet et al. 2009; 
Vallier, Mendjan et al. 2009), we hypothesized that Nodal/Activin signalling is crucial for 
Dies1 effect. This hypothesis was confirmed by treating Dies1 knock-down cells with the 
chemical compound SB-431542 which specifically inhibits Nodal/Activin pathway. The 
treatment with SB-431542 restores proper differentiation ability of Dies1 knock-down cells 
in the absence of LIF. Thus, the inhibition of Nodal/Activin pathway is able to rescue 
Dies1 knock-down effect. However, the effect of Dies1 suppression on Nodal and Activin 
signalling pathway seems to be indirect, as the level of phosphorylated and thus active 
Smad2/3 in Dies1 knock-down cells is identical to controls. In addition, Dies1 suppression 
does not exert any effect on Nodal/Activin response in luciferase assays. Our hypothesis is 
that the up-regulation of Nodal/Activin targets could be the consequence of the down-
regulation of BMP4 signaling pathway. One possibility is that the decreased amount of 
active SMAD 1/5/8 in Dies1 knock-down makes SMAD4 more available for SMAD 2/3 
complex. Such a regulation between Nodal/Activin and BMP4 is supported also by the 
observation that the down-regulation of BMP type I receptor Alk3 exerts the same effect of 
Dies1 knock-down on the transcription of the Nodal/Activin targets. Taken together our 
results suggest that the balance between BMP4 and Nodal/Activin exerts a crucial role in 
regulating ES cell pluripotency and differentiation. Thus, the identification of players 
regulating these signalling cascades will be very useful for the use of ES cell in therapy. 
In conclusion, we have identified Dies1 as novel component of BMP4 signaling pathway 
which is involved in ES cell pluripotency and differentiation. The generation of animal 
models, as knock-out mice, will be crucial to elucidate the role of Dies1 in vivo in embryo 
development. Moreover, these models will be useful to further investigate the functional 
interaction between Dies1 and BMP4 in developmental processes and in adult organs as 
well as to shed light on uncovered Dies1 functions.  
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